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ABSTRACT OF DISSERTATION

SALEN ALUMINUM COMPOUNDS IN THE DEALKYLATION AND DETECTION OF
ORGANOPHOSPHATES
The focus of this dissertation is the use of aluminum Schiff base compounds,
Salen(tBu)AlBr (SAB), in the dealkylation and detection of organophosphates (OPs). Three SAB
compounds, Salen(tBu)AlBr (1), Salpen(tBu)AlBr (2), and Salophen(tBu)AlBr (3) were used to
dealkylate a variety of trialkyl OPs. These reactions lead to unique organic-soluble aluminum
phosphate compounds containing six-coordinate aluminum. Examples include
[salen(tBu)AlOP(O)(OCH3)2]n (4), [salen(tBu)AlOP(O)(OCH2CH3)2]n (5), [salen(tBu)AlOP(O)(OPh)2]n
(6), [Salophen(tBu)AlOP(O)(OCH3)2 (7), Salpen(tBu)AlOOP(O)(OiPr)2 (8). These compounds are
unique examples of polymeric (4, 5, 6 and 7) and dimeric compounds (8) with salenAl units
connected by phosphate linkages. The compounds do not decompose in neutral water. This is
an advantage in the use of SABs for the deactivation of phosphate esters such as nerve agents.
Water-soluble and stable group 13 salen complexes, Salen(SO3Na)MNO3 (M =Al (19), Ga
(22)), Salpen(SO3Na)MNO3 (M = Al (20), Ga (23)), and Salophen(SO3Na)M(NO3) (M = Al (21), Ga
(24)) were synthesized by using water-soluble Salen(SO3Na) ligand. All the compounds were
characterized by various analytical techniques: 1H, 13C NMR, IR, and melting point.
One SAB was used to detect the nerve agents (NA). Salen(tBu)Al(Ac), prepared in situ
from Salen(tBu)AlBr and NaAc, forms Lewis acid-base adducts with the NAs, GB (sarin) and GD
(soman), and the VX hydrolysis product, EMPA, in aqueous solution. The [Salen(tBu)Al(NA)]+
compound is sufficiently stable to allow the identification of the NA with ESI-MS. Molecular ion
peak was detected for every compound with little or no fragmentation. The distinctive MS
signatures for [Salen(tBu)Al(NA)]+ compounds provide a new technique for identifying NAs in
aqueous solution.
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Chapter 1
1.1.

Introduction

Organophosphates

1.1.1. Structure
Phosphorus is a versatile element. It can form a variety of compounds including
inorganic salts (sodium, ammonium, and calcium salts of phosphate, for example), transition
metal complexes and organophosphorus compounds. Phosphorus has a high affinity for oxygen,
and organophosphate compounds, which contain phosphorus-oxygen linkages, are probably the
most important class of compounds in phosphorus chemistry. They may contain up to six oxygen
atoms linked to a central phosphorus atom (Figure 1.1).

Figure 1.1. Organophosphorus compounds (a: phosphite ester, b: orthophosphate, c:
organophosphate Esters, d: pentaoxyphosphoranes, e: hexaoxyphosphorides, f: phosphenites,
g: phosphenates)
The term phosphate is used to refer to compounds in which the central phosphorus
atom is linked to four oxygen atoms in a tetrahedral geometry (Figure 1.1 b and 1.1 c). If other
atoms or groups replace some of the oxygen, the compounds are referred to as substituted
phosphates (Figure 1.2).

Figure 1.2. Substituted phosphate
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Organophosphates (OP) are usually esters, amides or thiol derivatives of phosphoric
(H3PO4), phosphonic (H3PO3) or phosphinic (H3PO2) acids. Thus, phosphates are esters of
phosphoric acid with four oxygen atoms surrounding a phosphorus atom. In phosphonates
(esters of phosphonic acid), there are three O atoms and one P-C bond. Esters of phosphinic
acid, i.e. phosphinates, have two O atoms and two P-C bonds. Phosphate esters contain one or
more P-O-C linkages where the P-O (~359 KJ mol-1) and C-O (~355 KJ mol-1) bonds are of
comparable energy.1

Figure 1.3. General structures of (a) Phosphate, (b) Phosphonate, and (c) Phosphinate
Phosphates play an important role in living systems. They appear in many biochemical
reactions either as energy carriers, as coenzymes or as intermediates. DNA, RNA, and ATP are
some of the examples of phosphate biomolecules. Phosphates, found in biological systems, are
tetracoordinated with either tetrahedral or trigonal pyramidal geometry. OPs also play an
important role in science and technology. A large number of OPs were used in the agriculture
industry as pesticides and insecticides. Triaryl phosphates are used as additives for gasoline,
plasticizers, lubricants, coolants, and flame-retardants.

1.1.2. Bonding
The nature of the bonding in the P-O bond in phosphoryl compounds (R3PO) has been
the subject of great interest for many years. It has been reviewed extensively in the literature,2,3
and experimental work and calculations both agree that the P-O bond is strong, polar, and short
enough to be classified as a double bond.
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A variety of resonance structures have been proposed including R3P=O, R3P+-O-, partial
double bonds, formal triple bonds, and various resonance mixtures of these structures. A purely
donor bond, X3PO is proposed on the basis that amine oxides have this kind of bond. In
theory, bond angle data could be used to check the possibility of PO link. Phosphoryl
compounds with a PO link should have bond angles approaching the tetrahedral angle of
109.28°. Observed XPX bond angles for X3PO which are in the range of 102.5° for F3PO to 108°
for Br3PO.4 This bond angle data may consider as an evidence for the PO link. However, in
adduct F3PBH3 where there is definitely the formation of a donor σ bond, FPF bond angle is
99.8°. Hence, bond angle argument is inconclusive and steric factor dominate the geometry.
Recently, an abinitio nuclear magnetic resonance calculation5 and an atoms-in-molecule study6
concluded that a P-O bond is a better described as being zwitterionic R3P+-O-. It is also proposed
that this bond cannot be represented as a conventional multiple bond.5 However, other
evidences (P-O bond length, bond energy, dipole moments) point towards the existence of a PO
π bond. For example, the P-O bond in phosphoryl compounds is certainly stronger than a
conventional PO single bond. The P-O bond dissociation energy in the compounds containing
the phosphoryl group is in the 500-600 kJ mol-1 range (e.g. P-O bond energy in (EtO)3PO is 630 kJ
mol-1)7 while the P-O bond energy in compounds of the type (RO)3P is around 400 kJ mol-1.8 The
phosphoryl link is also significantly shorter than other PO bonds. For example, the PO bond
length in (MeO)3PO is 1.52 Å, which is shorter than the MeO-P bond length, 1.66 Å. 9 The dipole
moments of R3PO (e.g. 4.37 D for Me3PO) are smaller than the analogous nitrogen compounds
R3N-O (5.02D for Me3N-O), and suggests the presence of a double bond character in the
phosphoryl bond. In other words, there is expansion of octet on phosphorus and there is back
bonding from oxygen to suitable orbitals on phosphorus. This results in the formation of π
systems along with a donor σ bond.

3

Even though experimental and theoretical studies have proven the polar and multiple
bond character of P-O bond, there is still strong debate over the exact electron distribution
between P and O. Involvement of d orbitals in a π bond was proposed and this concept was well
reviewed in 1970.10 According to this approach, the π bond is formed by back donation of lone
pairs from oxygen to empty 3d orbitals of P. Some theoretical chemists have questioned this
concept2, and the role of d function is proposed as polarization functions rather than a primary
valence orbital.11 Currently, bonding in phosphoryl compounds is mostly discussed using 3
alternative views:12 1. One dative P-O σ bond and two π bonds formed by back bonding of two
oxygen lone pairs to suitable R3P antibonding orbitals. (Fig. 1.4a) 2. One dative P-O σ bond and
the negative hyperconjugation of three n0 orbitals with R3P antibonding orbitals. (Fig. 1.4b) 3.
Three ‘Banana / Bent multiple bonds. A PO bond, in this case, is viewed as a formal triple bond.
Differences in the description of the PO bond arise in the interpretation of interaction between
the R3P group and the O atom based on different approaches. (Fig 1.4c)

Figure 1.4. Alternative views for description of the P – O bond in phosphryl compound.
(Adapted from J.Com.Chem. 2013,34,149 with permission from J. Wiley & Sons) (License
number 3332610970405)

1.1.3. Reactivity Trends
The phosphate ester bond plays an important role in various systems ranging from
biological molecules, such as DNA, RNA, ATP, and commercial products, like plasticizer,
pesticides and nerve agents.13 Reactions of phosphate esters, typically called phosphate-transfer
reactions, play an important role in the chemical process of life. Reactions of trialkyl phosphates
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are simple and follow the predictions of Pearson’s theory of hard and soft reagents. Small
nucleophiles such as hydroxide, alkoxide, enolates, thiolates, phenyllithiums, and Grignard
reagents yield products arising from a nucleophilic attack on phosphorus, while bulky
nucleophiles such as bromide, iodide and benzyl lithium yield products arising from nucleophilic
attack on carbon.
1.1.3.1. Hydrolysis, Alcoholysis
The hydrolysis of trialkyl phosphates in an alkaline medium is a first-order with respect
to both hydroxyl ion and ester, and proceeds with the cleavage of P – O bond.14 The attack of
the hydroxyl group on the phosphoryl group is a one-step reaction and formulated as a
concerted SN2 type reaction (Scheme 1.1). There is strong evidence for inversion of
configuration in nucleophilic addition to the phosphoryl group.15 Also, there is no observed
exchange of oxygen between the phosphoryl group and water.16

Scheme 1.1. Alkaline hydrolysis of trialkyl phosphate
In a neutral or weak acidic aqueous media, hydrolysis of trialkyl phosphates proceeds
via breakage of the C – O bond.16 This reaction involves bimolecular attack. The protonation of
the ester oxygen is followed by attack of a water molecule on the carbon atom (Scheme 1.2).
However, in a strong acid, the direct attack of the hydroxyl ion on the phosphorus is observed.
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Scheme 1.2. Hydrolysis of trialkyl phosphate in neutral or weak acidic medium
Hydrolysis of trialkyl phosphates follows the predictions of Pearson’s theory of hard and
soft acids and bases. The hard base, hydroxide ion preferentially attacks the phosphoryl group
of trialkylphosphate and results in P – O cleavage. C –O bond cleavage is expected when a soft
base, water, attacks the soft acid, R+.17
In phosphonates and phosphinates, the alkyl groups do not participate in π bond and
thus increases the positive charge on phosphorus in comparison to the trialkyl phosphate.
Hence, alkaline hydrolysis is favored and acid hydrolysis becomes more difficult.18 In fact,
experimentally, a decreasing alkaline and an increasing acid stability are found in the order:
phosphates, phosphonates and phosphinates.
1.1.3.2. Nucleophiles other than hydroxyl Ion
Transesterification of trialkyl phosphate can be easily achieved by the nucleophilic
attack of alkoxide ion on P. Even though this process has been used for the synthesis of different
trialkyl phosphates, the mechanism of this reaction has not been studied extensively. This
reaction is likely to proceeds in the same manner as the hydrolysis.19 This is also a fundamental
reaction in enzyme inhibition by organophosphates.
Ammonia always reacts with triesters by C – O cleavage with the exception of triaryl
phosphates. A nucleophilic attack of ammonia displaces a phenoxide ion from triaryl phosphates
to form phosphoramides.20 Amines react in SN2 fashion at ester carbon of phosphate esters
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(Scheme 1.3). In the same manner, triesters are dealkylated by mercaptans, which react mostly
via C – O bond fission to give thioesters21 (scheme1.4).

Scheme 1.3. Reaction of amine with phosphate ester

Scheme 1.4. Reaction of mercaptan with phosphate triester
Bromide and iodine are typical soft bases that attack the alkyl carbon (soft acid) and are
effective reagents for dealkylation of phosphate esters.22 On the other hand, a fluoride anion
(hard base) is very reactive towards phosphorus.23,24

1.1.4. Industrial Applications
1.1.4.1. Flame Retardants
Flame retardants are compounds added to materials in order to make them more
resistant to ignition. Fire retardants slow the combustion process and restrict the spreading of
fire. Verity of compounds falls under this category. They may contain halogens (bromine and
chlorine), phosphorus, nitrogen, or metal-based (aluminum and magnesium) minerals or FR may
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be compounds containing borax or nanocomposite. 25,26Although the halogen-containing
compounds are constantly considered to be very effective FRs, emission of dense and toxic
smokes as well as corrosive gases during their combustion is the main concern. Brominated FRs
are toxic to humans and animals. Also, they are known to be persistent and bio-accumulative in
the environment. Phosphorus flame retardants are considered suitable alternatives for
brominated flame retardants.27
The range of phosphorus-containing flame retardants is extremely wide since the
element exists abundantly. There are three main groups of phosphorus flame retardants.26 The
first group contains inorganic phosphorus flame retardants. Red phosphorus and ammonium
polyphosphate are some examples of inorganic flame-retardants. An organic phosophate is a
second type of flame retardant. Phosphines, phosphine oxides, phosphonium compounds,
phosphonates, phosphites, and phosphate are all used as flame retardants in polymer. The third
group is comprised of halogenated phosphates.
The basic mechanisms of flame retardancy vary depending on the specific flame
retardant.25 Halogenated flame retardants function in the gas phase. Chlorine and bromine
atoms from these FRs react with H. and OH. radicals from the flammable gas phase resulting in a
slowing of the burning process. Another way to inhibit combustion is to provide a thermal
insulation barrier between the burning material and the unburned part. Phosphorus flame
retardants mainly act through this mechanism in the solid phase of the burning material. The
capability of organophosphorus flame retardants to inhibit ignition and promote char formation
is maximized in the solid or condensed phase. Upon heating, they react to form a polymeric
form of phosphoric acid that causes a char layer. Organophosphorus flame retardants are more
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effective in oxygenated polymers like wood, cotton, polyurethanes, polyesters, etc. where char
formation is an effective means to limit further burning.27
Aliphatic phosphates and phosphonates, particularly spirocyclic bisphosphate derived
from pentaerythritol, are commonly used as flame retardants in poly(ethylene terephthalate)
(PET), polyurethane foam (PUF), and epoxy resin.

Figure 1.5. Structures of organophosphate flame retardants, triphenyl phosphate (a),
(resorcinol-bis(diphenyl)phosphate) (b), (polysulfonyldiphenylene phenyl phosphonate) (c),
(polysulfonyldiphenylene thiophenyl phosphonate) (d), [poly(2, 2-dimethylpropylene
spirocyclic pentaerythritol bisphosphate)] (e), [poly(2-hydroxy propylene spirocyclic
pentaerythritol bisphosphate
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1.1.4.2. Plasticizers
Organophosphate compounds can be incorporated in plastics to increase flexibility or
workability. The first commercial use of an OP plasticizer took place before World War I where
triaryl phosphate was used in plasticizing cellulose nitrate and cellulose acetate.1 The more
important phosphate plasticizers are trioctyl phosphate (tri-2-ethylhexyl phosphate) and octyl
diphenyl phosphate (2-ethylhexyl diphenyl phosphate), which are used in PVC. In addition, tri-nbutyl phosphate, triethyl phosphate, tributoxyethyl phosphate, tri(p-tert-butylphenyl)
phosphate, and hexnyl diphenyl phosphate have been used commercially.28
Phosphates plasticizers, are generally high-boiling liquids, which when added to
polymers, reduce polymer-polymer interactions at the expense of polymer-plasticizer
interactions. This increases segmental mobility (movement of small chain of segments due to
correlated motion of several consecutive bonds) and polymer flexibility. There are two theories,
which have been put forward to explain the mechanism of plasticization.28 According to the
Lubricity Theory the small plasticizer molecules act as a lubricant between adjacent
macromolecules and separate polymer chains. Gel Theory considers a plastic as a three
dimensional gel. According to this theory, plastic brittleness and stiffness due to a closely packed
three-dimensional network structure formed by secondary bonding between macromolecules.
Plasticizer molecules eliminate the secondary preferential interaction with these sites. This
reduces the extent of the gel structure of plastic.
Phosphate plasticizers are generally preferred over the other types of plasticizers like
phthalates and citrates because they exhibit some unique desirable characteristics. The
phosphate plasticizers are known to increase the low temperature flexibility of plastics. Trioctyl
phosphate is particularly useful for imparting low temperature flexibility to plastic. The
phosphates are also used as flame-retardants for polymer systems.
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1.1.4.3. Pesticides
OP is a very effective and widely used class of pesticides. OP pesticides have replaced
organochlorine pesticides, which are more persistent in environment. OP pesticides are esters
of phosphoric or phosphorothionic acid that exist in two forms: thion (sulfur containing, P=S)
and -oxon (oxygen containing, P=O).29 The -oxon OPs have a greater toxicity than -thion OPs.
However, -thion OPs are readily hydrolysed to -oxons once they are in the environment. The
majority of OP pesticides in use are dimethyl compounds (two [-OCH3] groups attached to the
phosphorus) or diethyl compounds (two [-OC2H5] groups attached to the phosphorus). The
general structure of organophosphate pesticides is shown in Figure 1.6.

Figure 1.6. General structure of organophosphate pesticides (X is leaving group)
OP pesticides were first synthesized in Germany in the late 1930s. Many of the first OPs
were extremely toxic and some were developed into potential warfare agents during World War
II (e.g. soman, sarin, and tabun). Tetraethylpyrophosphate (TEPP) was first reported as an OP
pesticide. It was extremely toxic and highly unstable to hydrolysis under aqueous conditions.30
Parathion (O, O-diethyl-O-p-nitrophenyl phosphorothioate) was the first OP to be
marketed commercially. Subsequently, its oxygen analog, paraoxon (O, O-diethyl-O-pnitrophenyl phosphate) was synthesized. Other OPs that are frequently used include phosmet,
methyl parathion, chlorpyrifos, diazinon, and malathion. Presently, there are 49
organophosphate compounds registered as pesticides with the Environmental Protection
Agency (EPA).31
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OPs attack the nerve system to kill target pests, usually insects. However, they can also
attack the nervous systems of humans. Exposure to OPs can cause both acute and chronic
health effects. Acute exposure of OPs affects the parasympathetic, sympathetic, and central
nervous systems.32 The primary reason for OP toxicity is its inhibition of the acetyl
cholinesterase (AChE), enzyme responsible for hydrolysis of neurotransmitter acetylcholine. The
inhibition of the enzyme, AChE by OP mimics the reaction of AChE with Ach, except that
formation of phosphorylated enzyme results instead of the acetylation. The phosphorylated
enzyme is quite stable towards hydrolysis, causing loss of catalytic activity. This results in the
accumulation of ACh at neural junctions and subsequent overstimulation of nerve fibers.33
Phosphorylated AChE can undergo two possible reactions: recovery and aging. Recovery of the
enzyme occurs by hydrolytic removal of the OP, but the rate of hydrolysis is very slow. In the
case of pesticides, the half-life of the AChE-OP adduct is several hours. Aging occurs when the
enzyme-bound OP is dealkylated. Once aging takes place, the inhibited enzyme cannot be
reactivated.

Scheme 1.5. Inhibition of acetyl cholinesterase by organophosphate pesticide
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1.1.5. Chemical Warfare Agents
Chemical warfare agents (CWAs) have long been considered the “poor man’s atomic
bomb”.34Among weapons of mass destruction, CWAs are considered the most lethal and brutal
weapons made by the man. CWAs are inexpensive and relatively easy to produce, even by small
terrorist groups, although their extreme toxicity makes handling difficult. The potential use of
chemical warfare agents could be for various purposes, including causing mass casualties,
warfare, terrorism, assassination, deterrence, or special purposes. Based on the structure, CWAs
can be classified as organophosphorous (OP), organosulfur, organofluorine or arsenicals. Based
on their biological effects they can be divided into several types; nerve agents, vesicants, blood
agents, pulmonary agents and incapacitating agents.
1.1.5.1. Nerve Agents
Nerve agents (NA), which are organophosphorous derivatives, are the most significant
among different types of CWAs with respect to their toxicity, past use, mode of action, and
military capacity. There are two main groups of NAs, G and V agents.35 G agents, the first
generation of NAs, contain a typical P-F or P-CN bond. They include the cyanophosphoramidate,
tabun (GA), and the methylflurophosphonates, sarin (GB), soman (GD), and cyclosarin (GF)
(Figure 1.7). G agents can enter into the body through inhalation. However, venomous agents,
which are abbreviated as V agents, are more persistent in the environment and can be absorbed
through skin. This group of methylphosphothioates includes VX (Great Britain), RVX (Russian
VX), and CVX (Chinese VX) (Figure 1.7).
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Table 1.1. Abbreviations and chemical names of nerve agents35

Acronym

Chemical Name

GA (Tabun)

o-Ethyl N,N-dimethyl phosphoramidocyanidate

GB (Sarin)

o-Isopropyl methylphosphonofluoridate

GD (Soman)

o-Pinacolyl methylphosphonofluoridate

GF
(Cyclosarin)
VX
RVX
CVX

GA

o-Cyclohexyl methylphosphonofluoridate
o-Ethyl S-2-diisopropylaminoethyl
methylphosphonothioate
o-Isobutyl S-2-diethylaminoethyl
methylphosphonothioate
o-butyl S-2-diethylaminoethyl methylphosphonothioate

GB

VX

GD

RVX

Figure 1.7. Structures of nerve agents
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GF

CVX

1.1.5.2. Biological Effects
NAs are more toxic than non-OP CW agents. NAs are extremely toxic and they have very
rapid effect. If a person is exposed to high concentration of NA, e.g., 200 mg of sarin/m3 death
can occur with in a minute of exposure. The recent use of NAs was the use of sarin gas during
the Iraq-Iran conflict in the Gulf War, and during the terrorist attack in the Japanese subway.
The most recent use was in Damascus, Syria on Aug 21 2013, when around 1400 people were
killed in a sarin attack.36
Table 1.2. Toxicity of the most important nerve agents37

LCt50 Inhalation

LD50 Skin

mg.min/m3
Tabun

70

mg/ individual
4000

Sarin

35

1700

Soman

35

300

VX

15

10

NA poisoning causes contraction of pupils, profuse salivation, convulsions, involuntary
urination and defecation, and eventual death by asphyxiation as control is lost over respiratory
muscles. In Syria, victims of a sarin attack experienced headaches and nausea, excessive saliva,
and redness and itching of the eyes. The symptoms reported by doctors and witnesses included
vomiting, foamy salivation, severe agitation, dyspnea (Impaired breathing), neurological
convulsions, respiratory and heart failure, and blood out of the nose and mouth. In some cases,
hallucinations and memory loss were also observed.38 The effects of NAs are very long lasting
and increase with successive exposures. Survivors of NA poisoning almost invariably suffer
chronic neurological damage. This neurological damage can also lead to continuing psychiatric
effects.
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NAs prove so fatal because they inhibit an enzyme called acetylcholinesterase (AChE).
Inhibition occurs through the irreversible binding of an OP to a catalytic site of the enzyme.3941

This enzyme is responsible for hydrolysis of neurotransmitter acetylcholine, a key-signaling

molecule that has numerous functions in the body, including facilitating cognitive functioning
and triggering muscle contraction. The inhibition of AChE leads to an accumulation of
acetylcholine, resulting in continuous stimulation of nerve fibers.
During normal functioning of AChE, a catalytic triad of three amino acids, serine,
glutamic acid, and histidine, located in an active site of enzyme, catalyzes the hydrolysis of
acetylcholine.42,43The catalytic mechanism consists of two steps: (1) nucleophilic serine hydroxyl
group attacks acetylcholine (Ach) to form an acetylated enzyme with the release of choline
(Scheme 1.6 a & b); (2) nucleophile attack of a water molecule, activated by a histidine
molecule, on an acetylated enzyme to give a free enzyme and acetic acid (Scheme 1.6 c& d).
Catalytic efficiency of AChE is very high. AChE hydrolyzes more than 104 molecules of Ach per
second.44
The mechanism of AChE inhibition by OP is similar to the initial steps of the reaction of
an enzyme with Ach. Nucleophilic serine attacks the phosphorous atom of an OP molecule to
form a phosphorylated enzyme with the loss of a leaving group from OP. However, in the
second step, the catalytic histidine cannot activate a water molecule due to the loss of a
favorable conformation triad.45,46 Therefore, the rate of hydrolysis of a phosphorylated enzyme
is extremely slow compared to acetylated enzyme.47 Hence, phosphorylated enzymes can no
longer hydrolyze ACh leading to the accumulation of ACh in cholinergic receptors.
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Without functioning AChE, muscle fibers twitch uncontrollably and neurons in the brain
become hyperactive, leading to seizures. If untreated, people exposed to sarin typically die of
asphyxiation, as the muscles involved with breathing proceed to fire nonstop.

Scheme 1.6. Mode of action of the enzyme acetylcholinesterase

17

Scheme 1.7. Inhibition and aging of AChE with organophosphate nerve agents
1.1.5.3. Reactions
1.1.5.3.1.

Hydrolysis

1.1.5.3.1.1

G agents

Hydrolysis of NAs is considered a basic method of detoxification.48G agents are soluble
in water, and their hydrolysis is studied under different pH conditions.49-51 Hydrolysis of G agents
is temperature- and pH-dependent, and proceeds via SN2 nucleophilic attack at phosphorus. The
rate constant is much smaller for hydrolysis at neutral pH compared to the rate constant of
acidic and basic hydrolysis. At a pH value greater than 10, both GB and GD hydrolyzed within a
few minutes to their corresponding phosphonic acids (Scheme 1.8). Acid decreases the pH of the
reaction, which results in a decrease in the rate of hydrolysis. Hence, an excess of the base is
required to maintain the reaction rate.
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Scheme 1.8. Hydrolysis of soman and sarin
1.1.5.3.1.2

VX

Hydrolysis of VX is more complex, and the mechanism of hydrolysis depends on pH and
temperature. It involves several pathways (Scheme 1.9).52 It proceeds either via P-C or P-S bond
cleavage. At a pH value less than than 6 and greater than 10, cleavage of the P-S bond is the
predominant process, resulting in the formation of ethyl methylphosphonic acid (EMPA) and
diisopropylethyl mercaptoamine (DESH). The rate of hydrolysis is very slow at neutral or weakly
basic conditions (Half life of 60 h). As shown in Scheme 1.9, one of the reaction paths leads to
the formation of the stable but extremely toxic compound, S-(2diisopropylaminoethyl)methylphosphonothioic acid (EA-2192). Therefore, unlike the G agents,
VX cannot be detoxified by base-catalysed hydrolysis. EA-2192 can be hydrolyzed to DESH and
methyl phosphonic acid, but at room temperature, the rate of hydrolysis is extremely slow.
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Scheme 1.9. Hydrolysis of VX
1.1.5.3.2.

Reaction with H2O2

Basic peroxide has been known to decontaminate GB or sarin for decades53,54via the
formation of strong nucleophilic peroxy anion, HOO-. The reaction proceeds through the
formation of a peroxyphosphonate intermediate (Scheme 1.10).55 The reaction of G agents56,57
and VX58 with H2O2 is kinetically more favored compared to simple hydroxide. Although,
perhydrolysis is fast, G agents can be easily decontaminated by a dilute alkali. Hence, peroxide
offers no real advantage for these agents.

Scheme 1.10. Perhydrolysis of sarin
It was shown that VX also undergoes rapid perhydrolysis to give selectively P-S
cleavage.55,59Unlike a base hydrolysis of VX, a reaction with peroxide gives non-toxic ethyl
methyl phosphonic acid (EMPA). The N-oxide of VX also forms and similarly undergoes
perhydrolysis to give EMPA (Scheme 1.11) Hence, perhydrolysis of VX is a much more effective
decontamination reaction compared to the reaction with alkali, as toxic S-(2-
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diisopropylaminoethyl)methylphosphonothioic acid (EA-2192) is avoided. The reaction is
dependent on pH and an addition of bicarbonate as a buffer is required to avoid slowing of the
reaction due to the formation of an acid product.55

Scheme 1.11. Perhydrolysis of VX
1.1.5.3.3.

Reaction with Alkoxide Anions

Alkoxide anion in alcohol is an attractive system for dissolution and destruction of NAs.
An alkoxide solution can be prepared by simple mixing of alcohol with Na or K metal. Reactivity
of alkoxide anion increases with an increase in size of the alkyl group (R) of alcohol. The reaction
of VX with alkoxide proceeds with P-S cleavage and it involves displacement of thiolate by the
alkoxide ion (Scheme 1.12). However, unlike perhydrolysis of VX, alkoxide does not give
exclusive P-S cleavage. Cleavage of some of the P-O bonds is also observed to give thioate ester
intermediate, CH3P(O)(OR)O-, which is similar to VX. It further undergoes reaction with another
alkoxide ion to form CH3P(O)(OR)2.60 Diols (e.g., ethylene diglycol), ether alcohols, or amino
alochols (monoethanolamine, MEA) are also used to generate an alkoxide anion. The reactivity
of an alkoxide ion increases as the solvent becomes less protic.59
When NaOH or KOH is used to generate an alkoxide ion or when water is present in the
reaction system, the hydroxide anion OH – competes with RO – to react with VX. This reaction will
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produce toxic thionic acid species [MeP(O)(SCH2CH2Ni-Pr2)2OH], which react with an alkoxide ion
very slowly.59 (t1/2 = 140h at 0.30 M CH3O-, 22°C)

Scheme 1.12. Reaction of VX with alkoxide anion
1.1.5.3.4.

Other Reactions

1.1.5.3.4.1

Metal Ion Catalyzed Hydrolysis

The kinetic study of hydrolysis of sarin shows that Cu(II) is a better catalyst compared to
a number of metals (e.g., cerous, manganous ion) studied.49,61 Two mechanisms for the
activation step are possible. The catalytic species could be the hydroxometal complex, CuOH +,
or Cu(II) could act as a Lewis acid by complexing with the substrate at the phosphoryl oxygen
center followed by the attack of the hydroxide ion on the phosphate-Cu complex.62 Very few
reports are available on hydrolysis of VX catalyzed by Cu (II). The diethylamino group of VX
competes with phosphoryl oxygen for complexing with copper. Thus, the reaction is expected to
be inhibited if Cu(II) complexes with diethylamino group instead of phosphoryl group.52
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1.1.5.3.4.2

Oxidation

Since G-type nerve agents can be easily hydrolysed in basic media, an oxidation study is
more useful for V-type nerve agents. A solution or solid form of bleach is more commonly used
for decontamination of nerve agents. The representative reaction of nerve agents with bleach is
shown in (Scheme 1.13). In an acidic solution, tertiary amine nitrogen gets protonated, and
oxidation takes place at sulfur followed by hydrolysis of the P-S bond. At high pH, the tertiary
amine is oxidized to the stable N-oxide more rapidly than the sulfur is oxidized. In this case,
where nitrogen is only oxidized, detoxification is not effective since an N-oxide product is also
toxic and an excess of active chlorine is required for oxidation at sulfur.52

Scheme 1.13. Reaction of GB (a) and VX (b) with hypochlorite
The rate of the reaction of sarin with hypochlorite can be increased by the addition of a
surfactant. For example, sarin can be completely oxidized within 10 minutes at a
sarin/hypochlorite ratio of 20:1 in the presence of CTABr (cetyl trimethylammonium bromide).
In the absence of a surfactant, it takes more than 70 minutes.63
The number of oxidants containing peroxygen such as m-CPBA (m-chloroperoxybenzoic
acid), peroxyacetic acid, and MMPP (magnesium monoperoxyphthalate) were found to be
effective in the oxidation of VX in an aqueous solution.
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1.1.5.3.4.3

Autocatalytic Hydrolysis

The V-agents, VX and R-VX, can be completely hydrolyzed within 1-2 months at room
temperature to non-toxic products (a) and (d) (Scheme 1.14) in the presence of a stoichiometric
amount of water.64 The reaction is initiated by the attack of the deprotonated phosphonate (b)
on protonated VX (VXH+) to produce the diphosphonate intermediate (c). Toxic diphosphonate
rapidly undergoes hydrolysis to give acid (a), which is a carrier of the chain reaction.

Scheme 1.14. Autocatalytic hydrolysis mechanism of VX and R-VX
1.1.5.4. Deactivation and Destruction
After World War I and II, large numbers of stockpiled weapons and significant quantities
of bulk agents were disposed of or destroyed. Volatile or gaseous chemicals such as phosgene
were released into the atmosphere, and chemical weapons were disposed of by burning in an
open-pit. The most commonly used methods included dumping them into the sea, and land
burial. A very slow release of these chemicals due to containment corrosion led to the
contamination of soil and ground water. Also, there is a possibility of a sudden release of nerve
agents due to an explosion of sunken munitions. Hence, these methods represent long-term
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environmental threats and according to the Chemical Weapons Convention, which was signed
on April 29, 1997, these methods are no longer acceptable methods for the destruction of
chemical weapons.65 Other disposal techniques were studied and many of them are still under
consideration.65-67 There are two common methods that the United States uses to dispose of
chemical warfare agents and weapons. The primary method is incineration and another method
is hydrolysis with supercritical oxidation.

1.1.5.4.1.

Incineration

Incineration is an environmentally safe method for toxic waste disposal, provided that
the temperature used is sufficiently high for complete decomposition of organic chemicals to
simple inorganic chemicals. Incineration of chemical warfare agents will produce hydrogen
fluoride (GB), nitrogen oxide (GA and VX), phosphorus pentaoxide (GA, GB and VX), and sulfur
dioxide (VX). All of these can be removed by scrubbing. The incineration process for GB and VX is
shown in Scheme 1.15.

Scheme 1.15. Incineration process for sarin (a) and VX (b)
1.1.5.4.2.

Neutralization by Base Hydrolysis

Incineration is always an attractive destruction method, but there is always possible
danger of emission from the incineration facility. Neutralization is considered the best
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alternative to the incineration approach. Neutralization process conditions vary depending on
the type of agent to be destroyed. The US army is currently employing two neutralization
techniques for stockpile destruction: water hydrolysis followed by biotreatment and water
hydrolysis followed by supercritical oxidation.
Water hydrolysis followed by biotreatment was successfully employed at various US
army depots including Pueblo Chemical Depot.68 Mustard gas agents were hydrolyzed using hot
water followed by biotreatment, where ordinary bacteria consume neutralization byproducts. In
2003, neutralization followed by supercritical water oxidation was selected as technology to
destroy the chemical stockpile at the Blue Grass army Depot in Kentucky.68 After neutralization
and chemical analysis, the hydrolysate was heated to 600-650°C in the presence of air or oxygen
(oxidizing agent). Reaction mechanism generally follows free radical pathways that involve
oxidative radicals, such as OH and OOH. An organic compound is oxidized to water and sodium
carbonate, phosphate, and sulfate. The resulting reaction mass also contains a mixture of gases,
N2, O2, CO2. Salt separated from an aqueous solution by distillation of water followed by
filtration, is then sent to a landfill for disposal.
1.1.5.4.3.

Dealkylation

Dealkylation of organophosphate compounds by cleavage of the C-O bond is one of the
effective ways of deactivation of OP compounds. The Salen compounds, salben(tBu)[BBr2]2 and
salen(tBu)AlBr (Figure 1.8) can dealkylate CWAs, pesticides and their simulants under very mild
conditions.69 The reactions were conducted in NMR tubes and monitored by the disappearance
of the alkoxy peak of the phosphate and appearance of the alkyl peak of the alkyl bromide in the
1

H NMR spectrum. The percent conversion was calculated from the integration values. For

example, with VX the α-ethoxy proton peak appears as a multiplet centered near δ 4.15 ppm
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prior to reaction with salben(tBu)[BBr2]2. After 0.7 h this peak is observed along with the α methylene proton peak of ethyl bromide at δ 3.45 ppm.
Salben(tBu)[BBr2]2 was effective in cleaving only VX whereas GB (Sarin) and GD (Soman)
remained practically uncleaved in the 1:1 stoichiometric combinations. Salen(tBu)AlBr showed
significant dealkylation for VX, GB, and GD. All of these reactions were conducted in equimolar
quantities. It would be expected that much greater dealkylation would take place in shorter
periods of time using an excess of the salen reagent.

Figure 1.8. Salben(tBu)BBr2 and salen(tBu)AlBr

Scheme 1.16. Dealkylation of VX by salen(tBu)AlBr

Copyright © Rahul Butala 2014
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Chapter 2
2.1.

Salen-Supported Aluminum Phosphate Compounds

Introduction
Aluminum phosphate based material have been a subject of recent studies with respect

to their potential application as catalysts or catalyst supports, reactive fillers in polymeric
composites, analytical and industrial absorbent, flame retardants, etc.1,70 Polymeric structures
formed by self-assembly pathways of aluminophosphate species leading to one-dimensional
chain, two-dimensional porous layer, and three-dimensional open-framework materials are of
special interest.71 The synthesis of aluminophosphate polymers is typically carried out by a
hydrothermal reaction of H3PO4 with Al(OiPr)3 or aluminumoxohydride in the form of
pseudoboehmite, which is a source of aluminum.72 However, several aluminophosphates of
well-defined structures have been obtained by nonaqueous method.73-75 The dealkylation
reaction between trialkylaluminum and diphenylphosphoric acid has been used to synthesize
molecular aluminum phosphate. 76 Also, trialkyl aluminum undergoes adduct formation with
OP(OSiMe3) and the subsequent dealkylsilylation reaction to produce molecular
aluminophosphate.77 Most of molecular aluminum phosphate contains a four-coordinated
aluminum. [(AlOiPr)2O2P(OtBu)2]4 (five coordinated aluminum)78and [Al(O2P(OC6H5)2)3]n (six
coordinated aluminum)76 are some of the examples of higher coordinated aluminum
compounds reported in the literature.
Previously, our research group has shown that mononuclear aluminum Schiff base
compounds, Salen(tBu)AlBr (SAB) can effectively dealkylate a wide range of organophosphate
compounds79 including the chemical weapon agents (CWA), VX, GB (sarin) and GD (soman).69 As
one example, the compound salen(tBu)AlBr (SAB-1) cleaved 62% of the phosphate ester groups
in GD in just a 1:1 combination. The compound was also active in dealkylating VX and GB.
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Dealkylation of phosphate esters using SAB can be viewed as new method for deactivation and
decontamination of these compounds.
It would be interesting to elucidate the structures of the dealkylated products resulting
from the dealkylation of different phosphates with different SAB compounds. In this chapter the
synthesis, isolation, structural characterization, and the stability of the dealkylated products is
described. Dealkylation reactions were carried out using different stoichiometric ratio of SAB
reagent and trialkylphosphate. In these reactions the resulting product is a compound where
the dealkylated phosphate ester is covalently bound to the aluminum through Al-O-P linkage.

2.2.

Synthesis
The salen aluminum bromide compounds 1-3 were prepared by combining

diethylaluminum bromide and appropriate salen(tBu)H2 ligand, according to literature
procedure (Scheme 2.1).79 Dealkylation of different alkyl phosphates was carried out using
compounds 1-3 in equimolar ratio to give six coordinated aluminum phosphates, 4-8
(Scheme 2.2). The compounds were isolated by removing solvent under vacuum and
purified by recrystallization from hot toluene.

Scheme 2.1. Synthesis of Salen(tBu)AlBr
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R = (CH2)2

salen(tBu)AlBr (1)

R = (CH3)2

salpen(tBu)AlBr (2)

R = o-C6H4

salophen(tBu)AlBr (3)

R

R1

R’

(CH2)2

CH3

CH3

(CH2)2

CH3CH2

CH3CH2

(CH2)2

C6H5

(CH2)5CH3

o-C6H4

CH3

CH3

(CH2)3

CH(CH3)2

CH(CH3)2

[salen(tBu)AlOP(O)(OCH3)2]n (4)
[salen(tBu)AlOP(O)(OCH3CH2)2]n (5)
[salen(tBu)AlOP(O)(OPh)2]n (6)
[salophen(tBu)AlOP(O)(OCH3)2]n (7)
[salpen(tBu)Al(O)P(O)(OiPr)2]2 (8)

Scheme 2.2. Formation of Salen aluminum phosphate

2.3.

Characterization

2.3.1. Spectroscopy
Compounds 4-8 were characterized by NMR, IR, and MS. In 27Al NMR, no peak was
detected for compounds 4-7. The 27Al NMR for compound 8 shows two broad peaks. The peak
at δ 0.1 ppm represents six-coordinate aluminum and the peak at δ 30 ppm corresponds to fivecoordinate aluminum. However, solid-state structure of 8 shows presence of six-coordinate
aluminum only. Hence, one phosphate linkage from one of the aluminum atoms dissociate in
solution phase making it five-coordinate. This is confirmed by variable-temperature 27Al NMR. As
a temperature of the sample is lowered, intensity of a peak at δ 30 ppm decreased, and
eventually disappears at -50°C. The 1H NMR spectra of 4-8 were very close to the salen
aluminum phosphinate analogue, reported previously.80 1H spectra of 4-8 show two singlets for
t

Bu groups of the ligand in the range of δ 1.29 to 1.50 ppm with each peak corresponding to 18

protons. However, there is only one imine singlet in the range of δ 8.3 – 8.8 that indicates
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symmetric geometry around ligand backbone for these compounds in solution. There are
multiple CH2 peaks corresponding to the alkylene backbone protons from the ligand. For 4, 5
and 6 two methylene peaks corresponding to the backbone protons appear at δ 3.7 and 4.20
ppm. 1H NMR spectra of compound 8 show multiplet at δ 2.11, 2.29 and 4.19 corresponding to
protons from the ligand backbone (CH2CH2CH2). The 31P NMR spectra of 4-8 show single peaks at
δ – 6.58, -8.00, -19.87, -6.94 and -11.16, respectively. These 31P NMR shifts are upfield from the
chemical shifts of corresponding starting trialkylphosphate (Table 2.1), which indicate the
shielding of the phosphorus due to coordination to electropositive aluminum. The mass spectra
(EI) of 4-8 contained molecular ion peaks for corresponding monomer units. All the compounds
have a peak corresponding to the molecular ion minus one of the tBu group, and for compounds
4-6 this is the most abundant peak. The most abundant peak for compound 7 was one
corresponding to the molecular ion minus one of the tBu group and phosphate unit,
[OP(O)(OMe)2]. Mass spectra of compound 8 showed base ion peak form by loss of phosphate
unit, [OP(O)(OiPr)2] from the molecular ion.
Table 2.1. 31P NMR shifts
Compound

δ 31P

Starting alkyl phosphate

δ 31P

4

- 6.58

Trimethyl Phosphate

3.01

5

- 8.00

Triethyl Phosphate

- 0.24

6

- 19.88 2-ethylhexyldiphenyl phosphate - 11.09

7

- 6.94

Trimethyl Phosphate

3.01

8

11.16

Triisoprpyl phosphate

- 3.43
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2.3.2. Structures
2.3.2.1. Polymeric Salen Aluminum Phosphates
The solid-state structures of compounds 5-8 were determined by single-crystal X-ray
diffraction. Single crystal suitable for X-ray crystallography was obtained by slow evaporation of
either dichloromethane or chloroform solution. Table 2.2 lists selected bond lengths and angles
while the data collection parameters are contained in Table A 1. The molecular structure of 7
reveals the formation of polymeric chains of SalenAl unit connected by an O-P-O link (Figure
2.1). A similar kind of polymer formation was observed for compounds 5 and 6.

Figure 2.1. Crystal structure of 7 showing formation of polymer chain
Compounds 5 and 6 crystallize in orthorhombic space group P 21 21 21 and F d d d,
respectively whereas compound 7 crystallizes in tetragonal space group P 41 2 2. These
structures consist of a six-coordinated aluminum atom in a distorted octahedral geometry
(Figure 2.2, 2.3 and 2.4). The axial Al-O distances (~1.90 - 1.92 Ǻ) are longer than equatorial Al-O
distances (~1.80-1.82 Ǻ) due to the greater steric requirements of the axial groups. The axial OAl-O bond angles are distorted (~ 171.7 - 174.5°) from ideal linearity. The ligand occupies four
equatorial positions and bridging phosphate molecules occupy the two axial positions. Adjacent
t

Bu groups on ligands are arranged in staggered confirmation to reduce steric contact (Figure

2.5). All P atoms have distorted tetrahedral geometry with bond angles ranging from about

32

100.4° to about 119°. This is similar to the polymeric six coordinated aluminum phosphinate,
[Salen(tBu)Al(O2P(H)Ph)]n.81 In comparison, it is less distorted in derivative containing fourcoordinated aluminum such as [(tBu)2AlO2P(OC6H5)2]2 76 and [Me2AlO2POSiMe3)2]2.77 It is
interesting to note that out of four P-O bonds around the phosphorus center, P-O bonds of
bridging O-P-O linkage have a bond length (~ 1.48-1.49 Ǻ) close to a phosphorus-oxygen double
bond (1.45 Å); the other two P-O bonds from P-O-C units are longer and their bond lengths
(~1.56-1.58 Ǻ) fall in the range of P-O single bond (1.56 Å) (Table 2.2). All Al-O-P linkages are
bent in all three compounds. In compound 5, P1-O5-Al1 (162.55(14)°) is less bent than P1-O6Al2 (143.86(12)°). Similarly, in compound 6 Al2-O4-P1 (150.25(11)°) is less bent than Al1-O3-P1
(140.04(10)°). However, in compound 7 both the P-O-Al bond angles are similar (150.06(11)° and
148.87(10)°).

Figure 2.2. Crystal structure of 5
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Figure 2.3. Crystal structure of 6 (tBu groups omitted for clarity)

Figure 2.4. Crystal structure of 7
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Figure 2.5. Unit cell of 7 viewed down the c-axis showing staggered confirmation of tBu groups

2.3.2.2. Dimeric Salpen Aluminum Phosphate
The dimeric compound [salpen(tBu)AlOP(O)(OiPr)2]2 (8) resulted from the dealkylation
reaction of salpen(tBu)AlBr with triisopropyl phosphate in toluene at room temperature.
Selected bond lengths and angles are listed in Table 2.2 and the crystal data collection
parameters are shown in Table A 1. Compound 8 crystallizes in the monoclinic space group
P21/c. The molecular structure of 8 contains an aluminum-phosphate ring formed by two salen
aluminum units and two mono-dealkylated phosphate units (Figure 2.6). Apparently, the flexible
nature of the ligand backbones in these compounds allows for the dimerization to occur rather
than polymerization. The ring P-O bond distances P1-O3 and P1-O4 (1.4856 and 1.4886 Å
respectively) are essentially equal and have double bond character (Table 2.2). The other P-O
distances P1-O5 and P1-O6 (1.5735 and 1.5805 Å) are longer and in the range of P-O single
bonds.
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Figure 2.6. Crystal structure of 8
Each phosphorus atom is in a distorted tetrahedral geometry. The biggest distortion is
found in the O-P-O bond angle (118.81°) inside the aluminophosphate ring. Each aluminum
atom is six coordinated with distorted octahedral geometry. The phosphate oxygen atoms
occupy two of the equatorial positions. A nitrogen atom and an oxygen atom from the ligand
occupy the other two equatorial positions. Another pair of nitrogen and oxygen from ligand
occupies the axial positions. This is in contrast to polymeric structures discussed in previous
section where the phosphate oxygen atoms occupy axial positions, and nitrogen and oxygen
atoms from the ligand occupy equatorial positions. The axial Al-O distance (1.8277 Å) is slightly
shorter than equatorial Al-O distances (1.8507, 1.8625, 1.8944 Å). However, the axial Al-N2
distance (2.0380 Å) is almost equal to the equatorial Al1-N1 (2.0356 Å) distance. In Al-O-P
linkage, the Al-O-P angles are not equal. Al1-O3-P1 (164.11°) is larger than Al1O4-P1 (160.31°).
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Table 2.2. Selected bond distances (Å) and angles (°) for compounds 5-8
Salen(tBu)AlOP(O)(OEt)2 (5)
Al(1)-O(2)

1.809(2)

O(2)-Al(1)-O(1)

97.95(9)

Al(1)-O(1)

1.8105(19)

O(2)-Al(1)-O(5)

90.46(9)

Al(1)-O(5)

1.917(2)

O(5)-Al(1)-O(9)

174.50(9)

Al(1)-O(9)

1.9218(19)

O(10)-Al(2)-O(6)

174.58(9)

Al(2)-O(3)

1.802(2)

O(5)-P(1)-O(6)

115.02(11)

Al(2)-O(4)

1.818(2)

O(5)-P(1)-O(7)

111.05(12)

Al(2)-O(10)

1.917(2)

P(1)-O(5)-Al(1)

162.55(14)

Al(2)-O(6)

1.926(2)

P(1)-O(6)-Al(2)

143.86(12)

P(1)-O(5)

1.485(2)

O(10)-P(2)-O(9)

116.03(12)

P(1)-O(6)

1.492(2)

O(10)-P(2)-O(11)

111.09(12)

P(1)-O(8)

1.565(2)

O(9)-P(2)-O(11)

105.98(12)

P(1)-O(7)

1.574(2)

O(10)-P(2)-O(12)

105.3(2)

P(2)-O(10)

1.4850(19)

O(9)-P(2)-O(12)

108.7(4)

P(2)-O(9)

1.485(2)

O(11)-P(2)-O(12)

109.7(3)

P(2)-O(11)

1.576(2)

P(2)-O(12)

1.582(5)
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Table 2.2 (Continued)
Salen(tBu)AlOP(O)(OPh)2 (6)
Al(1)-O(1)

1.8028(17)

O(1)-Al(1)-O(2)

96.97(8)

Al(1)-O(2)

1.8034(19)

O(1)-Al(1)-O(3)

93.45(8)

Al(1)-O(8)

1.9460(17)

O(8)-Al(1)-O(3)

171.68(8)

Al(1)-O(3)

1.9524(17)

O(3)-P(1)-O(4)

116.94(9)

Al(2)-O(4)

1.9289 (15)

O(3)-P(1)-O(7)

106.01(10)

Al(2)-O(5)

1.8143 (17)

O(4)-P(1)-O(7)

110.56(9)

P(1)-O(3)

1.4834(17)

O(3)-P(1)-O(6)

111.51(9)

P(1)-O(4)

1.4841(17)

O(4)-P(1)-O(6)

110.07(9)

P(1)-O(7)

1.5843(17)

O(7)-P(1)-O(6)

100.40(9)

P(1)-O(6)

1.5848(17)

P(1)-O(3)-Al(1)

140.04(10)

P(1)-O(4)-Al(2)

150.25(11)

Salophen(tBu)AlOP(O)(OCH3)2 (7)
Al(1)-O(1)

1.8161(13)

O(1)-Al(1)-O(2)

96.72(6)

Al(1)-O(2)

1.8234(13)

O(3)-Al(1)-O(5)

172.09(7)

Al(1)-O(3)

1.8999(13)

P(1)-O(3)-Al(1)

150.06(8)

Al(1)-O(5)

1.9000(13)

P(2)-O(5)-Al(1)

148.87(10)

O(3)-P(1)

1.4829(12)

O(3)-P(1)-O(4)

106.62(7)

P(1)-O(4)

1.5730(14)

O(3)-P(1)-O(3)

119.27(10)

O(5)-P(2)

1.4794(13)

O(5)-P(2)-O(6)

104.57(14)

P(2)-O(6)

1.591(4)

O(5)-P(2)-O(5)

119.86(11)

O(6)-P(2)-O(6)

123.9(3)
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Table 2.2 (Continued)
Salpen(tBu)AlOP(O)(OiPr)2 (8)
Al(1)-O(1)

1.8277(11)

O(1)-Al(1)-O(2)

91.91(5)

Al(1)-O(2)

1.8507(10)

O(1)-Al(1)-O(3)

93.01(5)

Al(1)-O(3)

1.8625(10)

O(3)-Al(1)-O(4)

90.51(5)

Al(1)-O(4)

1.8944(10)

O(2)-Al(1)-O(4)

173.57(5)

Al(1)-N(1)

2.0356(13)

O(3)-Al(1)-N(1)

175.54(5)

Al(1)-N(2)

2.0380(13)

O(1)-Al(1)-N(2)

175.97(5)

O(3)-P(1)

1.4856(10)

O(3)-P(1)-O(4)

118.81(6)

O(4)-P(1)

1.4886(10)

O(3)-P(1)-O(5)

106.60(6)

P(1)-O(5)

1.5735(11)

O(4)-P(1)-O(6)

105.20(6)

P(1)-O(6)

1.5805(10)

O(5)-P(1)-O(6)

106.83(6)

P(1)-O(3)-Al(1)

164.11(7)

P(1)-O(4)-Al(1)

160.31(7)

2.3.2.3. Solution Phase structures
Gel Permeation Chromatography (GPC) was used to analyze the solution phase
structures of compounds 7 and 8. A GPC chromatogram of 7 (Figure A6 a) showed the
formation of dimeric and monomer species in solution phase, in contrast to polymeric
or oligomeric species in solid state. However, compound 8 is a dimer in solid state as
well as in solution phase (Figure A6 b).
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2.4.

Stability
For effective use of salen aluminum bromide compounds in decontamination of nerve

agents, it is necessary that the resulting products of this reaction are nontoxic, easy to handle,
and stable in environmental conditions. The significant aspect of the dealkylation of
trialkylphosphate using SAB is the formation of the solid compound possessing covalent Al-O-P
linkage. The structures of the dealkylated products reported above all show that dealkylated
phosphate ester are covalently bound to aluminum center through Al-O bond. Hence, in the
decontamination process of nerve agents using SAB reagents, the resulting product would be a
compound where the dealkylated nerve agent is bound to the aluminum center through a
covalent Al-O-P linkage. Thus, nerve agents can be deactivated and locked into salen units using
a dealkylation reaction.
In Al-O-P linkage, the Al-O bond distances (1.86-1.90 Å) are in the range of Al-O covalent
bond distance. The P-O bonds (1.48-1.49 Å) have double bond character. The literature reported
aluminum (III) meso-tetraphenylporphyrin complex axially bonded to phosphinate has an axial
Al-O bond distance of 1.86 Å and is stable in air and moisture.82 Hence, Al-O-P linkage of
resulting dealkylated product would be hydrolytically stable and it is unlikely that the aluminum
center will release dealkylated phosphate ester in the presence of water.
To confirm this assumption, a stability study of the salen aluminum phosphate was
carried out. In a typical experiment, compound 4 was suspended in water and resulting yellow
slurry stirred for several days. 1H NMR was used for monitoring the stability of the compound
and after three weeks the final compound was isolated by filtration and characterized by 1H and
31

P NMR, IR, MS (EI, positive), and melting point. The 1H NMR has peaks corresponding to the
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ligand and the methoxy groups of the mono-dealkylated phosphate. No peak corresponding to
aldehyde proton was observed suggesting the stability of imine bonds in the ligand backbone.
The 31P NMR has a single peak at δ -6.58 which is upfield compared to trimethylphosphate (δ
3.014) and dimethylphosphonic acid (δ 6.4).83 This suggests that phosphorous is coordinated to
the electropositive aluminum center through Al-O-P a linkage. Also the presence of only one
peak ruled out the release of dealkylated phosphate ester unit by hydrolysis of Al-O bond.

2.5.

Total Dealkylation
The salen aluminum phosphate compounds discussed in previous sections of this

chapter are monodealkylated products. Since the dealkylation reaction was carried out using an
equimolar ratio of trialkylphoshate and SAB, only one C-O bond of trialkyl phosphate was
cleaved to give monodealkylated product. For the deactivation of nerve agents the breaking of
only one C-O bond is required. Hence, the study of the monodealkylated products is important
and sufficient enough to explore the possible use of SAB compounds in nerve agent
deactivation. However, if a dealkylation reaction is carried out using stoichiometric amounts of
the SAB compounds and the trialkylphosphate (3moles of SAB per mole of phosphate), breaking
of all three C-O bonds take place to give a fully dealkylated product, [(SalenAlO)3PO].
Total dealkylation of trimethyl phosphate was carried out using compounds 1-3 in
stoichiometric amounts to give fully dealkylated products, 9-11 (Scheme 2.3). Although attempts
1

to isolate single crystal suitable for X-ray crystallography were not successful, H, IR, MS (MALDI)
analyses support the formation of fully dealkylated phosphate.
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R
(CH2)2

[(Salen(tBu)AlO)3PO] (9)

(CH2)3

[(Salpen(tBu)AlO)3PO] (10)

o-C6H4

[Salophen(tBu)AlO)3PO] (11)

Scheme 2.3. Total dealkylation of trimethyl phosphate
It was observed that the 1H NMR spectra have peaks corresponding to the ligand only
and no peak corresponding to the methoxy group of phosphate. MALDI mass spectra of the
compound 9, 10, and 11 show molecular ion peaks at m/z 1648, 1705, and 1807, respectively.
The isotope pattern from these spectra shows a very good match with the isotope pattern
obtained from the simulation experiment. For example, mass spectra of compound 9 (Figure 2.7
A) show six isotope peaks at m/z 1648 (93 %), 1649 (100%), 1650 (55 %), 1651 (22 %), 1652 (7
%), and 1653 (2 %), which is in good agreement with isotope simulation for (C96H139O10N6Al3P),
the molecular formula of compound 9 (Figure 2.7 B).
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A

B
Figure 2.7. A: MALDI mass spectra of 9; B: Isotope simulation for mol. wt 1648
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2.6.

Conclusion
The resulting products from the dealkylation reaction of a series of trialkylphosphates

using Salen(tBu)AlBr compounds have been isolated and fully characterized. These products are
soluble aluminum phosphate compounds where salen aluminum complex is axially bonded to
dealkylated phosphate molecule. These compounds are building blocks to obtain selfassembled structures. According to the number of methylene units in the salen ligand backbone,
resulting products are either chain or ring structures. The dealkylation has an important
application in deactivation of nerve agents. This study has highlighted two advantages of this
chemistry: 1) In Al-O-P linkage, the Al-O bond distances (1.86-1.90 Å) are in the range of Al-O
covalent bond distance. These aluminum phosphate compounds do not decompose in neutral
water Thus, dealkylated OPs will be held strongly by salen units. 2) In packing diagram, both
chain and ring structures appear as a column and phosphate units are arranged in the core of
this column (Figure A1 and A2). Hence, after deactivation nerve agents can be locked into salen
units.

2.7.

Experimental

General Remarks. All air-sensitive manipulations were conducted using standard bench top
Schlenk line technique in conjunction with an inert-atmosphere glovebox. All solvents were
rigorously dried prior to use. All glassware was cleaned with a base and an acid wash and dried
in an oven at 130°C overnight. Compounds Salen(tBu)AlBr (1), Salpen(tBu)AlBr (2) and
Salophen(tBu)AlBr (3) were synthesized according to the literature procedure.79 NMR data were
obtained on Varian Inova-400 instrument. Chemical shifts are reported relative to SiMe4 for 1H,
AlBr3 in D2O for 27Al and H3PO4 in D2O for 31P and are reported in ppm. Infrared transmission
spectra were recorded at room temperature in a potassium bromide pellet on a Fourier
transform Smart Omni transmission Nicolet is10 spectrometer.
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X-ray data were collected on a Bruker-Nonius X8 Proteum (Cu Kα radiation)
diffractometer. All calculations were performed using the software package SHELXTL-plus. The
structures were solved by direct methods and successive interpretation of difference Fourier
maps followed by least squares refinement. All non-hydrogen atoms were refined
anisotropically. The hydrogen atoms were included using a riding model with isotropic
parameters tied to the parent atom.
Isotopic distribution for the total dealkylated product was calculated using software
‘iso2l’, 2011 version.
Gel Permeation Chromatography (GPC) analysis was conducted on an Agilent Infinity
1260 HPLC equipped with Polymer Standard Services Suprema Linear S guard column (10 um, 8
X 50 mm) and Suprema Linear S analytical column (10 um, 8 X 300 mm). The eluent was a 1:1
mixture of DMSO: THF at a flow rate of 0.6 mL/min. Relative molecular weights were
determined by a calibration curve of polystyrene standards (65,000 Da, 30,000 Da, 13,500 Da,
4,000 Da, 906 Da) as well as phenyl ether (170g/mol). Polystyrene was monitored at a
wavelength of 272 nm while diphenyl ether were monitored at 280 nm. Compound 7 and 8
were monitored at 360 nm.
Synthesis of [Salen(tBu)AlOP(O)(OMe)2]n (4). To a rapidly stirred solution of Salen(tBu)AlBr (3.0
g, 5.02 mmol) in chloroform trimethyl phosphate (0.7 g, 5.02 mmol) was added. The reaction
mixture was stirred for 24 h at room temperature and filtered. The volatiles were removed
under vacuum from pale yellow filtrate to give yellow solid, which was purified by
recrystallization from toluene. Single crystals suitable for X-ray analysis were grown by slow
evaporation of toluene: dichloromethane mixture. Yield: 2.6 g (80.5 %). M.p.: 310-312°C. 1H
NMR (CDCl3): 1.27 (s, 18H, C(CH3)3), 1.46 (s, 18H, C(CH3)3), 3.08 (d, 6H, phosphate OCH3), 3.9 (s,
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br, 4H, NCH2), 7.04 (d, 2H, Ph-H), 7.53 (d, 2H, Ph-H), 8.38 (s, 2H, N=CH). 31P[1H] NMR(CDCl3): δ 6.58. IR (KBr, cm-1): 3041s, 2953w, 2906w, 2867m, 1651w, 1636w, 1550m, 1537m, 1476s,
1464m, 1257w, 1219m, 1075m, 1038w, 974s, 839m, 788m, 752s, 608m, 583m. MS (EI, positive):
642(M+, 24%), 585(M+ - tBu, 100%), 529(M+ - 2 tBu, 17%), 517(M+ - OP(O)(OMe)2, 7%).
Synthesis of [Salen(tBu)AlOP(O)(OEt)2]n (5). To a rapidly stirred solution of Salen(tBu)AlBr (0.9 g,
1.50 mmol) in chloroform triethyl phosphate (0.27 g, 1.505 mmol) was added. The reaction
mixture was stirred for 24 h at room temperature and filtered. The volatiles were removed
under vacuum from pale yellow filtrate to give yellow solid, which was purified by
recrystallization from toluene. Single crystals suitable for X-ray analysis were grown by slow
evaporation of dichloromethane solution. Yield: 0.80 g (80.0%). M.p.: 321°C. 1H NMR (CDCl3): δ
0.84 (t, 6H, phosphate OCH2CH3), 1.29 (s, 18H, C(CH3)3), 1.52 (s, 18H, C(CH3)3), 3.58 (m, 4H,
phosphate OCH2CH3), 3.74 (s, br, 2H, NCH2), 4.34 (s,br, 2H, NCH2), 7.05 (d, 2H, Ph-H), 7.54 (d, 2H,
Ph-H), 8.41 (s, 2H, N=CH). 31P[1H] NMR(CDCl3): δ -8.00. IR (KBr, cm-1): 3042s, 2956w, 2905w,
2868m, 1648w, 1545w, 1537m, 1477s, 1443m, 1245w, 1169m, 1060m, 965s, 874m, 787,m,
753s,606m, 583m. MS (EI, positive): 670(M+, 24%), 613(M+ - tBu, 100%), 517(M+ - OP(O)(OEt)2,
7%).
Synthesis of [Salen(tBu)AlOP(O)(OPh)2]n (6). To a rapidly stirred solution of salen(tBu)AlBr (1.05
g, 1.75 mmol) in chloroform 2-ethylhexyldiphenyl phosphate (0.636 g, 1.75 mmol) was added.
The reaction mixture was stirred for 24 h at room temperature and filtered. The volatiles were
removed under vacuum from pale yellow filtrate to give yellow solid. Yield: 0.82 g (61.2%).
M.p.: 262°C. 1H NMR (CDCl3): δ 1.32 (s, 18H, C(CH3)3), 1.48 (s, 18H, C(CH3)3), ), 3.68 (s, br, 2H,
NCH2), 4.25 (s,br, 2H, NCH2), 6.75 – 7.02 (m, 10H, P-O-C6H5), 7.01(d, 2H, Ph-H), 7.55 (d, 2H, PhH), 8.32 (s, br,0 2H, N=CH). 31P[1H] NMR(CDCl3): δ -19.88. IR (KBr, cm-1): 3064s, 3043s, 2954w,
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2903m, 2867m, 1643w, 1594w, 1538w, 1492m, 1477s, 1442m, 1235w, 1207m, 1122m, 941s,
814m, 753,m, 607m. MS (EI, positive): 760(M+, 30%), 709(M+ - tBu, 100%), 633(M+ - tBu - Ph,
15%), 517(M+ - OP(O)(OPh)2, 18%).
Synthesis of [Salophen(tBu)AlOP(O)(OMe)2]n (7). To a rapidly stirred solution of
Salophen(tBu)AlBr (0.84 g, 1.30 mmol) in chloroform trimethyl phosphate (0.18 g, 1.30 mmol)
was added. The reaction mixture was stirred for 24 h at room temperature and filtered. The
volatiles were removed under vacuum from pale yellow filtrate to give yellow solid, which was
purified by recrystallization from toluene hexane mixture. Single crystals suitable for X-ray
analysis were grown by slow evaporation of chloroform solution. Yield: 0.68 g (75.8%). M.p.:
344°C. 1H NMR (CDCl3): δ 1.36 (s, 18H, C(CH3)3), 1.53 (s, 18H, C(CH3)3), 3.04 (d, 6H, phosphate
OCH3), 7.191 (d, 2H, Ph-H), 7.37(m, 4H, Ph-H), 7.61 (d, 2H, Ph-H), 8.81 (s, br, 2H, N=CH). 31P[1H]
NMR(CDCl3): δ -6.94. IR (KBr, cm-1): 2950w, 2904m, 2866m, 2359s, 1617w, 1584w, 1531m,
1475s, 388m, 1218w, 1196m, 1051m, 863s, 846m, 594,m, 564s. MS (EI, positive): 690(M +, 63%),
675(M+ - CH3, 96%), 550(M+ - CH3 - OP(O)(OCH3)2, 100%).
Synthesis of [Salpen(tBu)AlOP(O)(OiPr)2]2 (8). To a rapidly stirred solution of salpen(tBu)AlBr
(1.43 g, 2.33 mmol) in chloroform triisopropyl phosphate (0.52 g, 2.33 mmol) was added. The
reaction mixture was stirred for 24 h at room temperature and filtered. The volatiles were
removed under vacuum from pale yellow filtrate to give yellow solid, which was purified by
recrystallization from toluene. Yield: 1.0 g (60.24 %). M.p.: 248 °C. 1H NMR (CDCl3): δ 0.91 (d,
12H, phosphate OCH(CH3)2), 1.29 (s, 18H, C(CH3)3), 1.48 (s, 18H, C(CH3)3), 2.21 (m, 1H,
CH2CH2CH2), 2.29 (m, 1H, CH2CH2CH2), 3.68 (m, 2H, phosphate OCH(CH3)2), 4.19 (m, 4H, NCH2),
7.02 (d, 2H, Ph-H), 7.50 (d, 2H, Ph-H), 8.27 (s, 2H, N=CH). 31P [1H] NMR (CDCl3): δ -11.16. IR (KBr,
cm-1): 3064s, 3031s, 2958w, 2898m, 2869m, 1640w, 1626w, 1551m, 1467s, 1441m, 1325w,
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1263w, 1171m, 1013m, 994s, 840m, 540s. MS (EI, positive): 712(M+, 7%), 530(M+ - OP(O)(OiPr)2,
100%).
Synthesis of (Salen(tBu)AlO)3PO (9). To a rapidly stirred solution of salen(tBu)AlBr (0.42 g, 0.70
mmol) in chloroform trimethyl phosphate (0.033 g, 0.23 mmol) was added. The reaction mixture
was stirred for 24 h at room temperature and filtered. The volatiles were removed under
vacuum from pale yellow filtrate to give yellow solid, which was purified by recrystallization
from toluene hexane mixture. Yield: 0.3 g (76.92 %). 1H NMR (CDCl3): δ 1.30 (s, 18H, C(CH3)3),
1.48 (s, 18H, C(CH3)3), 3.80 (s, br, 4H, NCH2), 7.05 (d, 2H, Ph-H), 7.52 (d, 2H, Ph-H), 8.3 (s, 2H,
N=CH). IR (KBr, cm-1): 2962m, 2905m, 2866m, 1648s, 1628s, 1544m, 1475m, 1444m, 1421w,
1390w, 1361w, 1310w, 1257w, 1180w, 867w. MS (MALDI, positive): 1648(M+, 100%), 1632(M+ CH3, 90%).
Synthesis of (Salpen(tBu)AlO)3PO (10). To a rapidly stirred solution of salpen(tBu)AlBr (0.95 g,
1.55 mmol) in chloroform trimethyl phosphate (0.072 g, 0.52 mmol) was added. The reaction
mixture was stirred for 24 h at room temperature and filtered. The volatiles were removed
under vacuum from pale yellow filtrate to give yellow solid, which was purified by
recrystallization from toluene hexane mixture. Yield: 0.6 g (68.96 %). 1H NMR (CDCl3): δ 1.30 (s,
18H, C(CH3)3), 1.50 (s, 18H, C(CH3)3), 2.23 (m, 2H, CH2CH2CH2), 3.65 (s, br, 2H, NCH2), 4.02 (s, br,
2H, NCH2), 7.02 (d, 2H, Ph-H), 7.50 (d, 2H, Ph-H), 8.23 (s, 2H, N=CH). IR (KBr, cm-1): 3064s, 3031s,
2956w, 2908m, 2866m, 1640w, 1626w, 1551m, 1467s, 1441m, 1325w, 1263w, 1171m, 1013m,
994s, 840m, 540s. MS (MALDI, positive): 1750 (M++ CH3, 100%), 1188 (M+ - salen, 10%), 531
(SalenAl, 15%).
Synthesis of (Salophen(tBu)AlO)3PO (11). To a rapidly stirred solution of salophen(tBu)AlBr (0.77
g, 1.2 mmol) in chloroform trimethyl phosphate (0.056 g, 0.40 mmol) was added. The reaction
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mixture was stirred for 24 h at room temperature and filtered. The volatiles were removed
under vacuum from pale yellow filtrate to give yellow solid, which was purified by
recrystallization from toluene hexane mixture. Yield: 0.5 g (70.4%). 1H NMR (CDCl3): δ 1.25 (s,
18H, C(CH3)3), 1.42 (s, 18H, C(CH3)3), 6.80 (m, 2H, Ph-H), 7.20 (d, 2H, Ph-H), 7.40 (m, 2H, Ph-H),
7.55(d, 2H, Ph-H), 8.4 (s, 2H, N=CH). IR (KBr, cm-1): 3064s, 3031s, 2961w, 2905m, 2869m, 1635w,
1626w, 1445, 1441m, 1325w, 1263w, 1171m, 1013m, 994s, 865w, 847m, 785s, 757w, 610m. MS
(MALDI, positive): 1807 (M++ CH3, 20%), 1256 (M+ - salen, 100%)
Aqueous Stability study: Nitrogen was bubbled through deionized water at atmospheric
pressure and 25°C for an indicated time. Initial pH was 6.7. Salen(tBu)AlOP(O)(OMe)2 (2.0 g, 3.1
mmol) was added to 20 mL of water and stirred for 3 weeks under N2 atmosphere. Yellow slurry
was filtered and washed with water. Recovery: 1.9 g (95 %). M.p.: 309° - 312° C. 1H NMR (CDCl3):
1.27 (s, 18H, C(CH3)3), 1.46 (s, 18H, C(CH3)3), 3.08 (d, 6H, phosphate OCH3), 3.9 (s, br, 4H, NCH2),
7.04 (d, 2H, Ph-H), 7.53 (d, 2H, Ph-H), 8.38 (s, 2H, N=CH). IR (KBr, cm-1): 3447w, 3041s, 2953w,
2906w, 2867m, 1651w, 1636w, 1550m, 1537m, 1476s, 1464m, 1257w, 1219m, 1075m, 1038w,
974s, 839m, 788m, 752s, 608m, 583m. MS (EI, positive): 642(M+, 24%), 585(M+ - tBu, 100%),
529(M+ - 2 tBu, 17%), 517(M+ - OP(O)(OMe)2, 7%).
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Chapter 3
3.1.

Water-Soluble Salen Aluminum Compounds

Introduction
Typical Salen ligands prepared by condensation of salicylaldehyde or its derivatives with

ethylenediamine or its derivatives are insoluble in water. By incorporating hydrophilic groups,
such as a sulfonate group or a carboxylic group, around the phenol portion of the ligand, the
ligands can be made highly soluble in water. The first synthesis of water-soluble salen complexes
was published in 1955.84,85 The metal complexes of the salen sulfonate ligand were prepared by
first sulfonating the preformed salen ligand with concentrated H2SO4, complexing the produced
sulfonic acid derivative of salen with the desired metal salt in EtOH, and finally neutralizing the
sulfonic acid groups with NaOH to form the disodium salt of the sulfonated complex. The imine
bonds in the salen structure are sensitive to hydrolysis in acidic conditions. Hence, very poor
yields are observed in this method. In the alternative method, reported in 1956,86 the sodium
salt of the sulfonated salicylaldehyde was used as a starting material. This aldehyde was
condensed with ethylenediamine in EtOH–H2O to form the desired ligand directly as disodium
salt.
Evans and coworkers have widely used this method for the preparation of sulfonated
salen complexes and their analogues, which were used for studies on singlet oxygen in aqueous
solutions.87-89 Co(sulfosalen) complex and its derivatives were prepared in a similar way, and
their reactions with dioxygen were studied.90 Very recently, chiral sulfonato-salen type
complexes of Ni(II), Cu(II) and Zn(II) synthesized by using the same strategy were published.91 In
addition to the sulfonate group, other hydrophilic groups like an ammonium group or a
carboxylic acid carboxylate group have been reported in the literature to produce a watersoluble salen ligand.92,93 Water-soluble Schiff base complexes have also been used as DNA
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cleavage catalysts. Many anionic and cationic water-soluble salen complexes have been
synthesized for these93,94 and other purposes.95
While studying the dealkylation of organophosphates using aluminum Schiff base
chelates, our ultimate goal is to make these compounds practically useful in the destruction of
nerve agents and pesticides. The series of SAB-X reported earlier is useful only in noncoordinating polar solvents for the dealkylation of phosphates. However, for possible
application of these compounds in destruction and decontamination of nerve agents and
pesticides, the dealkylation should be carried out in water. A major difficulty in conducting these
reactions in water is the hydrophobic nature of salen(tBu)AlBr. So our primary aim is to prepare
water-soluble compounds. This chapter describes the preparation and characterization of
water-soluble group 13 salen complexes.
Although the salen aluminum bromide compounds dealkylate organophosphates
compounds effectively in non-nucleophilic solvents, they might not be very effective in strong
donor solvents like methanol or water. It would be interesting to study the dealkylation of
organophosphates in different nucleophilic or donor solvents. This chapter also includes the
study of dealkylation of phosphate in different Lewis basic solvents using Salen(tBu)AlBr.

3.2.

Dealkylation in Lewis Basic Solvents
Previously, we have seen that chelated aluminum compounds, Salen(tBu)AlBr,

dealkylate a series of organophosphate esters by cleavage of the P-O-C linkage.79 However, this
study was carried out only in non-coordinating polar solvents (e.g. chloroform). In order to see
the effect of coordinating solvents, dealkylation of trimethyl phosphate was carried out in
different Lewis basic solvents. Salen(tBu)AlBr and trimethyl phosphate were stirred in different
solvents for 24 hours and the resulting product was separated by filtration. Solvents that can
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coordinate through oxygen atom, nitrogen atom are used in experiment. To compare the
percentage of the dealkylation, the reaction was repeated in chloroform (non-coordinating
solvent). Percentage yield is shown in Table 3.1.
Table 3.1. Percent Dealkylation of trimethyl phosphate in Lewis basic solvents

Trimethyl

Nerve Agent

Phosphate

VX

%

%

Solvent
Time
Time (h)

(h)

CHCl3

96

24

57

4

MeCN

57

24

15

9

THF

66

24

DMF

22

24

56

24

MeCN + H2O
(1:1)

In Lewis basic solvents, dealkylation of trimethyl phosphate is low compared to
chloroform. Lower percentage yield of the dealkylated product in Lewis basic solvents can be
explained with the help of the mechanism of the reaction. According to the proposed
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mechanism,79 Salen(tBu)AlBr forms a cation through coordination of a Lewis basic phosphate to
the aluminum center with the displacement of a bromide anion. This activates the α-carbon of
the phosphate for nucleophilic attack of the bromide (Figure 3.1). When the dealkylation
reaction is carried out in Lewis basic solvents, the solvent molecules compete with phosphate
molecules to coordinate to the aluminum center. It results in blocking of the coordination site of
aluminum. SalenAlX (X = Br- or OTs-) combinations with Lewis basic solvents, such as H2O,
methanol, or THF, are known to produce six-coordinated derivatives, several of which have been
structurally characterized.96
Note that all of these reactions were conducted in equimolar quantities and were
stopped after 24 hours. It may be possible that with a longer reaction time and using an excess
of the salen chelate we might observe a much greater percent dealkylation.

Figure 3.1.Dealkylation pathway of organophosphates with Salen(tBu)AlBr compounds

53

In an attempt to get a preliminary idea of the dealkylation of organophosphate nerve
agents in Lewis basic solvents, dealkylation of VX was carried out in acetonitrile. The reaction
was carried out in an NMR tube in CD3CN by using stoichiometric amounts of the Salen(tBu)AlBr
and VX. HMPA was used as an internal standard for 31P NMR. In an NMR spectrum of a starting
reaction mixture, two 31P peaks were observed at δ 23 and 52 corresponding to VX and HMPA,
respectively (Figure 3.2). After 9 hours a new peak at δ 10 was observed. Previously, it was
observed that HMPA is inert and Salen(tBu)AlBr does not show any activity towards cleaving a
P-N-C bond in HMPA.69 Hence, formation of the new peak confirms the dealkylation of VX. The
percent conversion was calculated from integration of the remaining phosphate and dealkylated
product. Only 15% conversion was observed after 9 hours, as opposed to 57% conversion after 4
hours when the reaction was carried out in CDCl3. The reaction had to stop due to the formation
of a precipitate.
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Figure 3.2. 31P NMR of dealkylation of VX with salen(tBu)AlBr ; top: at t = 0 h; bottom: at t = 9 h
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3.3.

Water-Soluble Salen Compounds
Salen(tBu)AlBr dealkylates organophosphate compounds in non-coordinating polar

solvents with high conversion rate at room temperature. However, for possible application of
these compounds in destruction and decontamination of nerve agents and pesticides, the
dealkylation should be carried out in water. A major difficulty in conducting these reactions in
water is the hydrophobic nature of salen(tBu)AlBr. So our primary aim is to prepare watersoluble compounds. This could be achieved by introducing sulfonate groups into salen ligand. In
the previous section, we have seen that in an acetonitrile-water mixture, salen(tBu)AlBr
dealkylates trimethyl phosphate to some extent. Hence creature of water stable system might
prove useful to carry out dealkylation in water.

3.3.1. Synthesis
The water-soluble salen ligands (16-18) were prepared by condensation of
salicyladehyde-5-sulfonate (15) with appropriate diamine following the literature procedure
(Scheme 3.1).97 Salicyladehyde-5-sulfonate (15) was selectively prepared by sulfonation of
protected aldehyde (14) and characterized by 1H NMR, IR, MS (EI positive) and X-ray analyses.
Salen group 13 complexes 19-24 were prepared in quantitative yield by combining the
Salen(SO3Na)H2 (16-18) with aluminum and gallium nitrate.
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R = (CH2)2

salen(SO3Na)H2 (16)

R = (CH3)2

salpen(SO3Na)H2 (17)

R = o-C6H4

salophen(SO3Na)H2 (18)

Scheme 3.1. Synthesis of Salen(SO3Na)H2

R

M

(CH2)2

Al

salen(SO3Na)AlNO3 (19)

(CH2)3

Al

salpen(SO3Na)AlNO3 (20)

o-C6H4

Al

salophenSO3Na)AlNO3 (21)

(CH2)2

Ga

salen(SO3Na)GaNO3 (22)

(CH2)3

Ga

salpen(SO3Na)GaNO3 (23)

o-C6H4

Ga

salophen(SO3Na)GaNO3 (24)

Scheme 3.2. Synthesis of Salen(SO3Na)MNO3
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3.3.2. Characterization
The preparation of water-soluble salen ligand is shown in Scheme 3.1. The approach to
ligand 16 requires sulfonation of the salicylaldehyde and then coupling with the
ethylenediamine. Sulfonation of protected aldehyde 13 selectively produced the parasulfonated compound 14, as confirmed by 1H NMR. Deprotection of the aldehyde group of
compound 14 gave compound 15, which was characterized by 1H NMR, IR, and mass
spectrometry. Water-soluble ligands 16-18 were prepared by condensation of two molecules of
15 with a molecule of appropriate diamine. Water-soluble ligands 16-18 were successfully
converted into their aluminum and gallium complexes by treatment with corresponding nitrate.
1

H NMR spectra of compound 15 showed doublet of doublet at δ 7.65 and two doublets

at δ 6.71 and 7.89 corresponding to protons of a phenyl ring. A singlet corresponding to
aldehyde proton was observed at δ 10.1.The mass spectra (ESI) of 15 show a single peak at m/z
201, which corresponds to the molecular ion minus sodium ion. The solid-state structure of
compounds 15 was determined by single-crystal X-ray diffraction. Single crystals suitable for Xray crystallography were obtained from water by slow evaporation. Table 3.1 lists selected bond
lengths and angles while the data collection parameters are contained in Table A 1. Figure 3.3
shows the molecular structure for compound 15. The structure of 15 contained SO3Na group in a
para position with respect to the aldehyde group. Also, it shows two water molecules associated
with sodium ion.
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Figure 3.3. Crystal structure of 15

Table 3.1. Selected bond distances (Å) and angles (°) for 15
S(1)-O(3)

1.4541(19)

O(3)-S(1)-O(4)

113.32(11)

S(1)-O(4)

1.4637(19)

O(3)-S(1)-O(5)

112.22(11)

S(1)-O(5)

1.4655(18)

O(4)-S(1)-O(5)

112.41(11)

S(1)-C(4)

1.772(2)

S(1)-O(3)-Na(1)

132.31(11)

Na(1)-O(3)

2.355(2)

O(3)-Na(1)-O(1W)

156.09(8)

Na(1)-O(1W)

2.329(2)

O(3)-Na(1)-O(2W)

107.01(8)

Na(1)-O(2W)

2.347(2)

O(2W)-Na(1)-O(1W)

90.24(8)
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Water-soluble ligands (16-18) were characterized by 1H NMR, IR and MS. 1H spectra for
16-18 contained only one imine singlet for each compound in the range of δ 8.3 – 8.9. For the
compounds 16 and 17 the peaks corresponding to the CH2 protons of the ligand backbone
appears in the range of δ 1.55 – 4.15. The IR spectra showed strong absorption due to νC=N at
1634, 1636 and 1621 cm-1 and medium absorption due to νS=O at 1357, 1367 and 1373 for 16-18,
respectively. In the mass spectra (EI), all three compounds had a peak corresponding to the
molecular ion minus sodium. All three ligands show very good water solubility, but are not
stable in water. When 1H NMR of these compounds was carried out using D2O, a singlet was
observed at δ 10.1 corresponding to the aldehyde proton. This indicates that the imine bond is
susceptible to hydrolysis in the presence of water.
Salen group 13 complexes (19-24) show only one imine singlet in the range of δ 8.458.92, which suggest a symmetrical structure in the solution state. For the compound 19, 20, 22
and 23 peaks corresponding to the CH2 protons of the ligand backbone appears in the range of δ
2.2 to 3.98. The IR spectra showed strong absorption due to νC=N in the range of 1621 to 1637
cm-1 and medium absorption due to νS=O in the range of 1357 to 1367 cm-1.
Unlike Salen(SO3Na)H2 ligands, their group 13 complexes show very good stability in
water. 1H NMR of these compounds was recorded in D2O. Prolong monitoring by 1H NMR for
possible hydrolysis does not show a peak corresponding to aldehyde even after several days.
This suggests that after coordination of group 13 metals, the imine bond of the salen ligand
becomes water stable and does not undergo hydrolysis.
Slow evaporation of aqueous solution of 19 gives a colorless, needle shaped crystal
suitable for X-ray analysis. Unfortunately, the X-ray structure could not be refined to an
acceptable R-value due to the large degree of disorder of sulfonate groups as well as ethylene
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backbone. Despite the disorder, we can confirm that the structures consist of a central sixcoordinate aluminium atom in a distorted Oh geometry with the Salen(SO3Na) ligand occupying
the four equatorial positions and the two water molecules in the axial positions.

Figure 3.4. Crystal structure of 19

3.4.

Conclusion
Salen(tBu)AlBr shows activity towards dealkylation of the organophosphate in Lewis

basic solvents like acetonitrile, tetrahydrofuran, etc. The rate of dealkylation in coordinating
Lewis basic solvents is slow compared to that in non-coordinating polar solvents like CHCl3.
Three water-soluble salen ligands and their group 13 metal complexes have been synthesized.
Salen(SO3Na)H2 ligand is unstable in water and undergoes hydrolysis to give starting aldehyde
and diamine. However, group 13 chelates are stable and do not show any hydrolysis product.
Unfortunately, these group 13 metal chelates do not show any activity in dealkylation of
organophoshate. This inactivity could be attributed to two coordinated water molecules. Water
is stronger Lewis base than trimethyl phosphate therefore phosphate cannot replace the
coordinated water molecule to become activated.96

3.5.

Experimental

General Remarks. All glassware was cleaned with a base and an acid wash and dried in an oven
at 130°C overnight. Starting materials for the synthesis were as follows: Salicyaldehyde (99%,
Across Org.), Aniline (99%, Alfa Aesar), ethylenediamine (99%, Across Org.), aluminum nitrate
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(98%, Aldrich), and gallium nitrate (99.9%, Alfa Aesar). The listed materials were used as
received without further purification. NMR data were obtained on Varian Inova-400 instrument.
Chemical shift are reported relative to SiMe4 for 1H and 13C. Infrared transmission spectra were
recorded at room temperature in a potassium bromide pellet on a Fourier-transform Smart
Omni transmission Nicolet is10 spectrometer.
X-ray data were collected on a Bruker-Nonius X8 Proteum (Cu Kα radiation)
diffractometer. All calculations were performed using the software package SHELXTL-plus. The
structures were solved by direct methods and successive interpretation of difference Fourier
maps followed by least squares refinement. All non-hydrogen atoms were refined
anisotropically. The hydrogen atoms were included using a riding model with isotropic
parameters tied to the parent atom.
Dealkylation of organophosphate in Lewis Basic solvent. In a typical experiment salen(tBu)AlBr
(0.5 g, 0.84 mmol) was dissolved in acetonitrile (20 mL). The clear solution was obtained after 5
minutes stirring to which trimethylphosphate (98 μL, 0.84 mmol), density 1.197g/mL) was added
with a syringe. The mixture was stirred for 24 hours at room temperature. Then it was cannula
filtered and the pale yellow residue was dried under vacuum. The % dealkylation was calculated
from the yield of the reaction.
Dealkylation of Nerve agents in Lewis Basic solvent. VX was obtained from Aberdeen Proving
Ground (APG). Trained personnel using applicable safety precautions conducted reactions with
chemical warfare agents on site at Edgewood Chemical and Biological Center at APG.
31

P NMR spectra were collected on samples prepared directly in NMR tubes using a

Bruker AVANCE 300 MHz NMR spectrometer fitted with 5 mm broadband probe. The reactants
were placed in a 4 mm glass NMR sleeve which was flame sealed and placed in a 5 mm glass
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NMR tube also flame sealed. The contents of the doubly sealed tube were then vortex mixed
and placed in the NMR probe. A 5 µL of VX (18.9 µmol) was reacted in equimolar quantities
with salen(tBu)[AlBr] (11.3 mg, 18.9 µmol) in at ambient temperature in 1.0 mL each of d3acetonitrile and CDCl3. A 5 µL of hexamethylphosphoramidate (HMPA) was added as an internal
standard. Percentage conversion was calculated from integration of the remaining phosphate
and dealkylated product.
Synthesis of sodium salicylaldehyde-5-sulfonate (15). Salicylaldehyde (20 g, 0.16 mol) was
charged into a 250 mL round bottom flask containing methanol (60mL). A solution of aniline
(14.8 mL, 0.16 mol) in methanol (40 mL) was added slowly over 30 minutes. The reaction
mixture was stirred at reflux temperature for 20 hours. The reaction mixture was allowed to
cool to room temperature and filtered on a Buchner funnel to isolate yellow crystalline
compound. Yield: 28.1 g (89.0 %). Mp: 50°C. 1H NMR (CDCl3): δ 6.93 (dt, 1H, Ph-H), 7.01 (d, 1H,
Ph-H), 7.28 (m, 3H, Ph-H), 7.38(m, 4H, Ph-H), 8.6 (s, 1H, N=CH)
This compound (5 g) was charged into a 100 mL round bottom flask containing five times its
weight of concentrated sulfuric acid, which gave upon stirring a clear orange solution. This
solution was heated for 2 hours at 110°C.The reaction mixture was allowed to cool at 0°C for 30
minutes, then ice pieces were added to induce crystallization of N-phenylsalicylaldimine-5sulfonic acid which was filtered on a Buchner funnel and washed with small quantities of icewater to remove excess sulfuric acid. Recrystallized from boiling water to afford yellow powder.
Yield: 6.2 g (88.57 %). 1H NMR (CD3OD): δ 6.82 (dd, 1H, Ph-H), 7.4 (m, 2H, Ph-H), 7.52(m, 3H, PhH), 7.64 (m, 1H, Ph-H), 7.9(s, 1H, N=CH). IR (KBR) γ/ cm-1: 3395w, 3055w, 1651s, 1605m, 1361m,
1180s, 1176s, 1113s, 1036s.
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This pure compound was dissolved in boiling water, and sodium carbonate (5 g) was added until
evolution of carbon dioxide ceased. Reaction mass was heated to boiling and nitrogen gas was
passed through reaction mixture to remove aniline. This process was repeated several times
until water vapor showed no alkaline response to pH paper. The aqueous solution was
evaporated to dryness, dissolved in ethanol and filtered to eliminate inorganic salt impurities.
The ethanol layer was evaporated under vacuum to give bright yellow sodium salicylaldehyde.
Yield: 3.07 g (61.2 %). Mp: 330 -332°C. 1H NMR (D2O): δ 7.05 (d, 1H, Ph-H), 7.95 (dd, 1H, Ph-H),
8.10 (d, 1H, Ph-H), 10.0(s, 1H, CHO). IR (KBR) γ/ cm-1: 3461w, 2758s, 1655w, 1598m, 1459w,
1398m, 1195w, 1106m, 840w. MS (EI, positive): 201(M+ - Na, 100%)
Synthesis of Salen(SO3Na)H2 (16). To a solution of sodium salicylaldehyde (1.5g, 6.6 mmol) in
methanol (50 mL) was added a solution of ethylenediamine (0.25 mL, 3.3 mmol) in a methanol
(10 mL). The resulting slurry was stirred at reflux temperature for 2 hours. Reaction mass was
allowed to cool to room temperature and filtered to isolate a nice yellow crystalline solid. Yield:
1.4g (80%). Mp: > 380°C. 1H NMR (CD3OD): δ 3.98 (s, 4H, NCH2), 6.8 (dd, 2H, Ph-H), 7.6 (d, 2H,
Ph-H), 7.98 (d, 2H, Ph-H), 8.62 (s, 2H, N=CH). IR (KBR) γ/ cm-1: 3537s, 3466s, 3411s, 3042s,
2893w, 1634s, 1611m, 1579m, 1483m, 1357m, 1184s, 1108s, 1053s, 1033s, 843s, 729 m.
Synthesis of Salpen(SO3Na)H2 (17). To a solution of sodium salicylaldehyde (1.2 g, 5.3 mmol) in
methanol (50 mL) was added a solution of 1,3 propylenediamine (0.32 mL, 2.6 mmol)) in
methanol (10 mL). The resulting solution was stirred at reflux temperature for 2 hours. Reaction
mass was allowed to cool to room temperature and filtered to isolate a nice yellow crystalline
solid. Yield: 0.6 g (77.9 %). Mp: > 380°C. 1H NMR (CD3OD): δ 2.1 (m, 2H, CH2CH2CH2), 3.7 (t, 4H,
NCH2), 6.8 (d, 2H, Ph-H), 7.6 (dd, 2H, Ph-H), 7.89 (d, 2H, Ph-H), 8.52 (s, 2H, N=CH). IR (KBR) γ/ cm-
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1

: 3537s, 3466s, 3411s, 3042s, 2942s, 2850s, 1636w, 1610w, 1581m, 1482m, 1367m, 1195w,

1107m, 729m.
Synthesis of Salophen(SO3Na)H2 (18). To a solution of sodium salicylaldehyde (1.5 g, 6.6 mmol)
in ethanol (50 mL) was added a solution of 1,2 phylenediamine (0.36 g, 3.3 mmol)) in ethanol
(20 mL). The resulting solution was stirred at reflux temperature for 2 hours. Reaction mass was
allowed to cool to room temperature and filtered to isolate a nice yellow crystalline solid. Yield:
0.7 g (72.1 %). Mp: > 380°C. 1H NMR (CD3OD): δ 6.95 (d, 2H, Ph-H), 7.4 (m, 4H, Ph-H), 7.8 (dd,
2H, Ph-H), 8.00 (d, 2H, Ph-H), 8.92 (s, 2H, N=CH). IR (KBR) γ/ cm-1: 3537s, 3466s, 1638w, 1610w,
1581m, 1482m, 1373m, 1195w, 1107m, 729w.
Synthesis of Salen(SO3Na) AlNO3 (19). A rapidly stirred solution of salen(SO3Na)H2 (0.5 g, 0.97
mmol) in methanol (30 mL) was combined with Al(NO3)3.9H2O (458 mg,0.93 mmol) followed by
addition of sodium acetate (380 mg, 2.82 mmol). Clear reaction mass was stirred for 15 hours.
Then it was concentrated under vacuum to about one third of its volume. The Yellow
precipitated was isolated by filtration, washed with cold methanol and dried under vacuum. Xray quality crystals were grown from slow diffusion of methanol vapor into a concentrated
aqueous solution of salen(SO3Na)AlNO3. Yield: 0.25 g (52%). 1H NMR (D2O): δ 3.98 (s, 4H, NCH2),
6.95 (d, 2H, Ph-H), 7.78 (dd, 2H, Ph-H), 7.83 (d, 2H, Ph-H), 8.45 (s, 2H, N=CH). IR (KBR) γ/ cm-1:
3530b, 3040s, 2942s, 2850s, 1636w, 1610w, 1581m, 1482m, 1367m, 1195w, 1107m, 729w.
Synthesis of Salpen(SO3Na) AlNO3 (20). A rapidly stirred solution of salpen(SO3Na)H2 (0.5 g, 1
mmol) in methanol (20 mL) was combined with Al(NO3)3.9H2O (412 mg,1.1 mmol) followed by
addition of sodium acetate (390 mg, 2.9 mmol). Clear reaction mass was stirred for 15 hours.
Then it was concentrated under vacuum to about one third of its volume. The Yellow precipitate
was isolated by filtration, washed with cold methanol and dried under vacuum. Yield: 0.36 g
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(62%). 1H NMR (D2O): δ 2.2 (m, 2H, CH2CH2CH2), 3.6 (t, 4H, NCH2), 6.8 (d, 2H, Ph-H), 7.6 (dd, 2H,
Ph-H), 7.9 (d, 2H, Ph-H), 8.5 (s, 2H, N=CH). IR (KBR) γ/ cm-1: 3545 b, 3042s, 2942s, 2850s, 1636w,
1610w, 1581m, 1482m, 1367m, 1195w, 1107m, 729w.
Synthesis of Salopen(SO3Na) AlNO3(21). A rapidly stirred solution of salopen(SO3Na)H2 (0.5 g,
0.97 mmol) in methanol (20 mL) was combined with Al(NO3)3.9H2O (400 mg,1.06 mmol)
followed by addition of sodium acetate (378 mg, 2.81 mmol). Clear reaction mass was stirred for
15 hours. Then it was concentrated under vacuum to about one third of its volume. The Yellow
precipitated was isolated by filtration, washed with cold methanol and dried under vacuum.
Yield: 0.36 g (62%). 1H NMR (D2O): δ 6.98 (d, 2H, Ph-H), 7.3 (m, 4H, Ph-H), 7.8 (dd, 2H, Ph-H),
8.00 (d, 2H, Ph-H), 8.92 (s, 2H, N=CH). IR (KBR) γ/ cm-1: 3540b, 3042s, 1636w, 1610w, 1581m,
1482m, 1367m, 1195w, 1107m, 729w.
Synthesis of Salen(SO3Na) GaNO3(22). A rapidly stirred solution of salen(SO3Na)H2 (0.5 g, 1.05
mmol) in methanol (30 mL) was combined with Ga(NO3)3.9H2O (0.48 g, 1.15 mmol). Clear
reaction mass was stirred for 15 hours. Then it was concentrated under vacuum to about one
third of its volume. The white precipitated was isolated by filtration, washed with cold methanol
and dried under vacuum. Yield: 0.4 g (63.5%). 1H NMR (D2O): δ 3.98 (s, 4H, NCH2), 6.95 (d, 2H,
Ph-H), 7.78 (dd, 2H, Ph-H), 7.83 (d, 2H, Ph-H), 8.45 (s, 2H, N=CH). IR (KBR) γ/ cm-1: 3537b, 3042s,
2942s, 2850s, 1636w, 1610w, 1581m, 1482m, 1367m, 1195w, 1107m, 729w.
Synthesis of Salpen(SO3Na) GaNO3(23). A rapidly stirred solution of salpen(SO3Na)H2 (0.505 g,
1.03 mmol) in methanol (30 mL) was combined with Ga(NO3)3.9H2O (0.477 g, 1.14 mmol). Clear
reaction mass was stirred for 15 hours. Then it was concentrated under vacuum to about one
third of its volume. The white precipitated was isolated by filtration, washed with cold methanol
and dried under vacuum. Yield: 0.35 g (55.5%). 1H NMR (D2O): δ 2.2 (m, 2H, CH2CH2CH2), 3.6 (t,
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4H, NCH2), 6.8 (d, 2H, Ph-H), 7.6 (dd, 2H, Ph-H), 7.9 (d, 2H, Ph-H), 8.5 (s, 2H, N=CH). IR (KBr) γ/
cm-1: 3530b, 3042s, 2942s, 2850s, 1636w, 1610w, 1581m, 1482m, 1367m, 1195w, 1107m,
729w.
Synthesis of Salopen(SO3Na) GaNO3 (24). A rapidly stirred solution of salopen(SO3Na)H2 (0.5 g,
0.96 mmol) in methanol (30 mL) was combined with Ga(NO3)3.9H2O (0.44 g, 1.05 mmol). Clear
reaction mass was stirred for 15 hours. Then it was concentrated under vacuum to about one
third of its volume. The white precipitate was isolated by filtration, washed with cold methanol
and dried under vacuum. Yield: 0.35 g (56.4%). 1H NMR (D2O): δ 6.98 (d, 2H, Ph-H), 7.3 (m, 4H,
Ph-H), 7.8 (dd, 2H, Ph-H), 8.00 (d, 2H, Ph-H), 8.92 (s, 2H, N=CH). IR (KBR) γ/ cm-1: 3537b, 1636w,
1610w, 1581m, 1482m, 1367m, 1195w, 1107m, 729w.
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Chapter 4
4.1.

Detection of Nerve Agents in Water

Introduction
Among the different types of Chemical Weapon Agents (CWAs) nerve agents (NAs) are

the most significant with respect to their toxicity, past use, military capacity and mode of action.
Exposure to G-type nerve agents such as GA (Tabun), GB (Sarin), GD (Soman) and V-type nerve
agents, such as VX, can take place through inhalation, contact with the eyes or skin, and by
ingestion. The G-type agents are not persistent and degrade, depending on conditions, within
hours when warm to days when cold. However, VX is highly persistent and the hydrolysis
product, ethylmethylphosphonic acid (EMPA), retains extreme toxicity and is highly watersoluble.
Efforts to prevent chemical weapon attacks or accidental releases prompted the
Chemical Weapons Convention (CWC) to mandate that countries must destroy all CWAs
stockpiles held in reserve.98 However, the use of CWAs by terrorists or non- signatory countries
is still a threat to civilian health and safety. The recent chemical weapon attack on civilians in
Syria has confirmed this threat. LC/MS and GC/MS analyses confirmed the use of Sarin in Syria.
One of the most difficult problems in responding to a CWA release is the
decontamination of any affected objects and detection of any residual CWA or degradation
products in complex environmental matrices. Several detection techniques like GC/MS99, ion
mobility spectrometry100 or flame photometric detection101 are commercially available. All
these techniques have their own pros and cons, for example flame photometric detection is fast
and sensitive but produces false positives. Ion mobility spectrometry operates at ambient
temperature but has low resolving power and limited selectivity.
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Mass spectrometric methods could provide identification of NAs. The most commonly
used method to detect NAs is GC/MS but the NA degradation products like alkyl
methylphosphonic acids must be derivatized before the analyses.102-104 Derivatization adds time,
difficulty, and increases the potential for exposure to the NAs. The most common derivatization
methods include the formation of trimethylsilyl (TMS) ethers or tert-butyldimethylsilyl (t-BDMS)
esters, methylation with diazomethane, and formation of an ion pair with trimethylphenyl
ammonium hydroxide (TMPAH). Most of these derivatives are unstable and moisture sensitive.
In particular, the use of diazomethane is problematic since it is explosive and carcinogenic.
Liquid chromatography coupled with mass spectrometry (LCMS) employing various ionization
techniques has also been used to detect NAs.105,106 LC/MS/MS and LC/ICP/MS have been used to
detect G-agents, V- agents and their degradation products. However, the low ionization
efficiency of G-type NAs makes LC/MS analyses difficult.
Salen(tBu)Al(Ac), prepared in situ from Salen(tBu)AlBr and NaAc, forms Lewis acid-base
adducts with G-type NAs, GB (Sarin) and GD (Soman), and the VX hydrolysis product EMPA in
aqueous solution. The resulting compounds, [Salen(tBu)Al(NA)]+[Ac]- are sufficiently stable to
identified by ESI-MS. This chapter presents results and discussion of the ESI-MS detection
method for the NAs and their degradation product in water.

4.2.

Research Background
Chapter 2 described how chelated salen aluminum bromide compounds effectively

dealkylate organophosphate compounds to give aluminum phosphate, where dealkyalted
phosphate is covalently bound to the aluminum center (Scheme 2.2). We have discussed the
proposed mechanism of this reaction in chapter 3. According to this mechanism, the
dealkylation reaction proceeds via formation of a cation through coordination of
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organophosphate molecule to aluminum (Figure 3.1). In an effort to confirm the formation of
such a cation, we attempted the isolation of a cation formed by the combination of
salen(tBu)AlBr with triphenylphosphine oxide in an equimolar ratio. Absence of a P-O-C linkage
in the phosphine oxide precluded the dealkylation. Hence, reaction should give a cation formed
by coordination of Lewis basic phosphine oxide to aluminum (Scheme 4.1). Although single
crystals suitable for X-ray analysis could not be isolated, a MALDI mass spectrum provides strong
evidence for the formation of a salen aluminum cation. MALDI mass spectra shows a peak (m/z
= 795) corresponding to [salen(tBu)AlOP(O)Ph3]+ (Figure 4.1). Thus, Salen(tBu)AlBr forms a Lewis
acid-base adduct with phosphine oxide that is sufficiently stable to identify by MS.

Scheme 4.1. Coordination of phosphine oxide to aluminum
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Figure 4.1. MALDI MS (+) of Lewis acid-base adduct of phosphine oxide with salen(tBu)AlBr
Similarly, Lewis acid-base adduct formation can be expected when NAs are combined
with Salen aluminum chelate. The detection of this adduct could provide a useful technique for
identifying NAs. Salen(tBu)Al(Ac) was prepared in situ by combination of Salen(tBu)AlBr and
sodium acetate. Unlike bromide anion, acetate anion is incapable of inducing dealkylation of
organophosphate compounds. Hence, when Salen(tBu)Al(Ac) was combined with G-type NAs,
GB (Sarin) and GD (Soman), and the VX hydrolysis product EMPA in aqueous solution, no
dealkylation was observed. These organophsphate compounds coordinate to aluminum to form
[Salen(tBu)Al(NA)]+[Ac]-, which was detected and identified by ESI-MS. Trained personnel using
applicable safety precautions conducted the study with chemical warfare agents at the
Edgewood Chemical and Biological Center at APG. Studies on NAs can only be conducted in
government-approved laboratories.
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4.3.

ESI-MS Analysis
Electrospray ionization-mass spectrometry (ESI/MS) has become an important

technique for characterization of biomolecules, inorganic species, and synthetic polymers. It is a
simple technique that takes place at atmospheric pressure and at a moderate temperature, and
is a “soft” ionization technique. The ionization is soft in the sense that a very little residual
energy is retained by the analyte, and generally no fragmentation occurs upon ionization. Not
only that but also very weak non-covalent interactions are preserved in the gas phase. Since
fragmentation of molecular ions is generally limited, mass spectra are relatively simple. ESI-MS
can be divided into three steps: Dispersal of a sample solution into electrically charged droplets,
generation of multiply charged ions from droplets by solvent evaporation, and transportation of
ions from ionization source to mass analyzer.
Schematic diagram of ESI is shown in Figure 4.2. With in ESI apparatus, a stainless steel
capillary needle is maintained at high voltage relative to a wall of a chamber that surrounds the
needle. When a sample solution is passed through the capillary, a mist of highly charged
droplets generates at the tip of the capillary. The electrospray of fine droplets then enters into
desolvating chamber, where solvent from droplets is evaporated with the help of elevated ESI
temperature and/ or stream of nitrogen drying gas. The charged droplets are continuously
reduced in size by evaporation of solvent, which results in an increase of surface charge density.
This process continues until a point called the Rayleigh limit, where the surface tension can no
longer support the charge. Here a so-called Coulombic explosion occurs and the droplet is torn
apart into smaller droplets. These droplets repeat the process until all solvent is removed from
the analyte, leaving a multiply charged analyte molecule. These ions are then accelerated into
the mass analyzer for analysis of molecular mass and measurement of ion density. To obtain
structural information, precursor ion of interest can be mass selected and further fragmented in
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collision cell. The fragmented ions can then be mass analyzed in second mass analyzer of a
tandem mass spectrometer system.

Figure 4.2. Sketch of the apparatus for electrospray ionization
(Reprinted from J.B. Fenn et al., Science, 1989, 65, 246. with permission from The American
Association for the Advancement of Science) (License Number 3471480189669)
The quadrupole mass analyzer: When ions travel through a magnetic or electrical field their
movements are affected by their m/z ratio and this is a main principle of separating ions in mass
analyzer. A quadrupole mass analyzer is composed of the four parallel cylindrical rods kept at
equal distance. (Figure 4.3) Opposite rods are connected electrically, one pair being attached to
the positive side of a variable DC source and the other pair to the negative terminal. In addition,
variable radio frequency ac voltage is applied to the diagonally placed pair of rods. Ions are
accelerated into the space between the rods by a potential difference of 5 to 10V. Resulting field
causes the ions to travel forward in the z direction with oscillatory motion in the x-y plane. The
ac and dc voltages on the rods are increased simultaneously while maintaining their ratio
constant. These voltages can be set so that all the ions except with desirable m/z value strike the
rods and are converted to neutral molecules. The only ions having limited range of m/z values
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oscillate with stable amplitude and reach the transducer without hitting the quadrupole rod.
Normally ions that differ in mass by one unit can be resolved.

Figure 4.3. Schematic diagram of a quadrupole mass spectrometer
In a tandem quadrupole system, which is often called “Triple quadrupole”, there are
three quadrupoles set up in a linear fashion. (Figure 4.4) Precursor ion, mass selected by first
quadrupole (Q1), enters into second quadrupole (Q2). There it reacts with a collision gas, or
interacts with an intense laser beam to produce fragments, called product ions. These ions are
then mass analyzed by the second mass analyzer (Q3) and detected by the ion detector. This
tandem system is commonly denoted as MS/MS in the literature.

Figure 4.4. Schematic diagram of a triple quadrupole system
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4.4.

Result and Discussion
Scheme 4.2 shows a sequence of reactions (a-c) leading to formation of Lewis acid-base

compounds between Salen(tBu)AlBr (1) and the nerve agents GB (Sarin) GD (Soman) and VX
hydrosylate EMPA (ethylmethylphosphonate). Salen(tBu)Ac is prepared in situ by a reaction of
SalenAlBr with NaAc. It is then combined with nerve agents to form Lewis acid-base adducts.
These resulting Lewis acid-base adducts, [Salen(tBu)AlNA]+[Ac]−, were identified by electrospray
ionization-mass spectroscopy (ESI-MS). Mass number for each compound in this sequence of the
reactions is give in Table 4.1
Table 4.1. Mass numbers for each compound formed in a sequence of reactions leading to
formation of Lewis acid-base compounds between salen(tBu)Al and the nerve agents
#

Compound

MW (g/mol)

1

Salen(tBu)AlBr

597.61

26

Salen(tBu)Al(OAc)

576.75

27

[Salen(tBu)Al(GB)]+

657.79

28

[Salen(tBu)Al(GD)]+

699.87

29

[Salen(tBu)Al(EMPA)]+

641.78

75

Scheme 4.2. Sequence of reactions (a – c) leading to formation of Lewis acid-base compounds
between salen(tBu)AlBr (1) (which forms the ion pair, [salen(tBu)Al(iPA)Br] (25) and the nerve
agents GB (sarin, R = CHMe2, X = F (27)) GD (soman, R = CH(Me)CMe3 X = F (28)) and VX
hydrosylate EMPA (ethylmethylphosphonate, R = Et, X = OH (29)).
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The ESI-MS of 1 in isopropanol was obtained as a baseline for comparison to the NA
derivatives. The positive ionization spectrum had m/z values attributed to [Salen(tBu)Al]+ (517)
from loss of bromide and [Salen(tBu)Al(iPA)]+ (577) with coordinated solvent (Figure 4.5). These
two peaks indicated that the compound readily loses bromide and that compounds with
coordinated Lewis bases could be detected. The assignment for m/z 1051 probably corresponds
to [{Salen(tBu)Al}2O]+ with a bridging oxide, a known structural motif for SalenAl compounds. In
the negative ionization mode the largest peak in the spectrum corresponded to
[{Salen(tBu)Al(iPA)(H2O)}Br] (m/z 675) which indicated that the compound and coordinated
solvent remained intact under the ESI-MS(+ and -) conditions (Figure 4.6).
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Figure 4.5. ESI-MS (+) of 1 in isopropanol
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Figure 4.6. ESI-MS (-) of 1 in isopropanol
It has been established that Lewis basic solvents such as H2O, MeOH, and
tetrahydrofuran displace the anion from SalenAl (X = Br− and OTs−, for example) to form
solvated six-coordinate derivatives.107 In the present study the bromide anion in 25 was
exchanged for acetate through a salt elimination reaction. The ESI-MS(+) spectrum detected 26
(m/z 577) without water, in addition to an acetate-bridged compound, [{Salen(tBu)Al}2Ac]+ (m/z
1093) (Figure 4.7). In negative ionization mode the largest peak for 26 was [Salen(tBu)Al(Ac)2]−
(m/z 635) and fragments corresponding to compounds containing bromide: [Salen(tBu)AlBr(Ac)]−
m/z 657 and [{Salen(tBu)Al}2Br(Ac)2]−, m/z 1233 (Figure 4.8). Such salen acetate compound is
known in literature.108 Salcen(tBu)AlOC(O)Me, formed by combination of salcen(tBu)AlMe with
acetic acid have been structurally characterized (Figure A3).
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Figure 4.7. ESI-MS (+) of 26
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Figure 4.8. ESI-MS (-) of 26
In separate experiments, aqueous solutions of 26 were combined with micromolar
quantities of GB (0.02 mM) and GD (0.02 mM) and EMPA (0.8 mM) to form the Lewis acid-base
adducts, [Salen(tBu)Al(NA)]+ (Scheme 1c). In positive ionization mode, parent peaks were
observed for the compounds containing GB (m/z 657, 27) and GD (m/z 699, 28) (Figure 4.9 and
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4.10). The peaks are weaker than that for 26 (m/z 577) due to the lower concentrations used,
but easily identified. Moreover, the peak at m/z 517 could correspond to loss of GD from 28 or
loss of Ac from 26. For 28, the MS/MS spectrum of m/z 699 has a peak at m/z 615, which is likely
due to loss of dimethyl butene (Figure 4.11). The positive ionization spectrum of 29 has a parent
peak at m/z 641 and another at m/z 1157 corresponding to dimeric, EMPA-bridged
[{Salen(tBu)Al}2(EMPA)]+ (Figure 4.12). Such dimeric compounds are known for SalenAl
combinations with phosphonic and phosphinic acids.81 [salpen(tBu)AlO2P(H)Ph]2,
[salben(tBu)AlO2P(H)Ph]2, [salohen(tBu)AlO2P(H)Ph]2 are some of the compounds which have
been structurally characterized. Acetate adducts are observed at m/z 577 and m/z 1093. In the
negative ionization spectrum (Figure 4.13), EMPA adducts were observed at m/z 699 for
[Salen(tBu)Al(EMPA)(Ac)]− and m/z 763 for [Salen(tBu)Al(EMPA)2]−.
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Figure 4.10. ESI-MS (+) of 28
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Figure 4.12. ESI-MS (+) of 29
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Figure 4.13. ESI-MS (-) of 29
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Table 4.2. Computational determination of ΔG values (kcal/mol) for the combination of
SalenAl cations with Ac- (a), water (b) and (c), G-type nerve agents (d-g) and EMPA (h)
Compound

L = Salen

L = Salen(Me)

a

LAl(Ac)

-33

-31.5

b

[L(Al)(H2O)]+

-19.8

--

c

[L(Al)(H2O)2]+

-26

--

[LAlP(O)(Me)(R)(X)]+
R

X

d

Me

F

-20.7

-19.6

e

CHMe2

F

--

-24.3

f

CH(Me)iPr

F

--

-19.9

g

CH(Me)tBu

F

--

-19.9

h

Et

OH

-24.3

--

(The X and R groups correspond to substitutions in Figure 1. The compound, [SalenAl]+ does
not have tBu groups while in [Salen(Me)Al]+ the tBu groups were replaced with Me to make
the computations manageable.)
Table 4.2. shows the computationally determined free energies for binding two types of
Salen-aluminum cations with acetate (Eq. 1) and NAs (Eq. 2). The calculations incorporate the
influence of hydration energy in the formation of 27, 28, and 29. The ΔG for Ac binding with 1 (33 kcal/mol) is greater than the ΔG values for the nerve agents, which implies that the
equilibrium should favor coordination of acetate over the NAs. However, the NAs are, by design,
hydrophobic so that they can readily penetrate human skin. In contrast, the acetate anion is
hydrophilic, meaning that the NA will segregate out of the aqueous phase to coordinate to the
more hydrophobic 26. The displacement of Ac− from the complex (Eq. 3) would be facilitated by
coordination of the NA to 26, forming a six-coordinate intermediate. This compound has

83

precedent in the X-ray structure of Salen(tBu)Al(OMe)(MeOH), where the Al is in a distorted
octahedral geometry.109
[Salen(tBu)Al(H2O)2]+ + [Ac]− → Salen(tBu)Al(Ac) (1)
Salen(tBu)Al(Ac) + NA ↔ Salen(tBu)Al(Ac)(NA) (2)
Salen(tBu)Al(Ac)(NA) → [Salen(tBu)Al(NA)]+ + Ac-(aq) (3)

4.5.

Conclusion
G-type nerve agents are difficult to analyze by LCMS due to low ionization efficiency.

Analyzing for nerve agents after coordination to [Salen(tBu)Al]+ has several advantages: 1)
reduction of low mass noise by moving the ion to higher mass (e.g. GB, MW 140.1, shifted to
m/z 657 with SalenAl), 2) ability to detect nerve agents and degradation compounds without
any additional water-sensitive derivatization, 3) additional sample preparation options based on
extraction of the Lewis acid complex, and 4) presumed reduction in toxicity due to the moderate
strength of the NA-Al coordinate covalent bond. Replacement of the tBu groups on the Salen
ligand with electron-withdrawing or more hydrophilic groups could be used to increase the
binding strength to particular compounds of interest and adjust the hydrophobicity of the
complex. Further work is still necessary to identify the Lewis Acid/Base adducts in solution
phase to determine their thermodynamic properties.

4.6.

Experimental

Synthesis and Characterization of Salen(tBu)AlBr (1). A rapidly stirred solution of Et2AlBr in
toluene, prepared in situ by the redistribution of triethylaluminum (0.75 g, 6.57 mmol) and
aluminum(III) bromide (0.89 g, 3.34 mmol), was combined with a solution of salen(tBu)H2 (5.0 g,
10.15 mmol) in toluene by cannula. The reaction mixture was refluxed for 8 h and filtered. The
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volatiles were removed under vacuum from the clear yellow filtrate to give a yellow
microcrystalline solid, which was purified by recrystallization from toluene. Yield: 4.8 g (79.20
%). mp: 330-332°C. 1H NMR (CDCl3): δ1.48 (s, 18H, C(CH3)3), 1.72 (s,18H, C(CH3)3), 3.93 (m, 4H,
NCH2), 7.35 (d, 2H, PhH), 7.43 (d, 2H, PhH), 8.56 (s, 2H, N=CH). IR (KBr; cm-1): 2962 (m), 2905
(w), 2866 (w), 1648 (s), 1628 (s), 1544 (m), 1475 (m), 1444 (m), 1421 (w), 1390 (w), 1361 (w),
1310 (w), 1257 (w), 1180 (w), 867 (w), 845 (m), 816 (w), 786 (w), 756 (w), 608 (m), 586 (w). MS
(EI, positive): m/z 597 (M+, 8%), 517 (M+ - Br, 100%).
Electro-Spray Mass Spectroscopy
Procedure and Instrumentation. Compound 1 was prepared as described in Section A. It was
transfered to a glass tube with a Teflon cap under nitrogen in an inert-atmosphere glovebox.
The glass tube was sealed in a fire-proof air-sealed aluminum container and shipped to ECBC,
MD.
At ECBC, compound 1 was used as received. It was dissolved in isopropanol at a stock
concentration of 4 mg/mL, and diluted further to make standards. The samples were prepared
by mixing (by volume) 10 μl of the stock solution with 100 μl of isopropanol, 10 μl of 0.5 M
ammonium acetate solution in water, and 1-10 μl of acid or G agent standards. The final
concentration of compound 1 was 0.55 mM. This concentration was not optimized, and a lower
concentration could decrease the amount of dimer formation.
The solution of 0.5 M ammonium acetate buffer was used to exchange Br− for acetate
anions, and to provide a buffer for electrospray mass spectroscopy. Solutions of analyte acid or
G agents were used at various concentrations.
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Samples were analyzed on a ThermoFinnigan TSQ Quantum triple quadrupole mass
spectrometer by flow injection at 5-50 μl/min with an electrospray ion source with default
conditions and tuning, and using nitrogen drying gas. The spectrometer was calibrated to unit
mass. Samples were analyzed in less than one hour after preparation.
Computational Study. The program package G09 was used for optimizations, frequency
calculations, and solvation calculation. Complexes were optimized and frequencies calculated at
the M05-2X/6-31+G(d) level while implicit solvation in water was modeled with SMD/B3LYP/631+G(2d,p). Estimated free energies of reaction were computed directly from SMD total
energies. When free energies were computed with zero-point energies, integrated heat
capacities and entropies using the equation DG(aq,298K) = DG(g,298K,M05-2X/M05-2X/631+G(d)) + DG(sol,SMD/B3LYP/6-31+G(2d,p)), the resulting free energies of reaction agreed to
within one kcal/mol.

Copyright © Rahul Butala 2014
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Chapter 5

Conclusion and Future Work

This research is based on the previous finding where mononuclear aluminum bromide
compounds based on the salen ligand effectively dealkylate a wide range of organophosphate
compounds including nerve agents and pesticides. Dealkylation of phosphate esters can be used
for deactivation and decontamination of these compounds. For effective use of this chemistry, it
is necessary to gain a full understanding of the reaction. It would be interesting to elucidate the
structures of the dealkylated products resulting from the dealkylation of different phosphates
with different SAB-X. The extreme toxicity makes it impossible to study nerve agents in an
academic research lab. Thus, dealkylation reactions were carried out using less
trialkylphosphate, which could be model compounds for toxic nerve agents. In these reactions,
the resulting product is a compound where the dealkylated phosphate ester is covalently bound
to the aluminum through an Al-O-P linkage. Unique organic-soluble aluminum phosphate
compounds containing a six-coordinate aluminum were isolated and structurally characterized.
The resulting compounds are either polymeric or dimeric depending on the number of
methylene units in the salen backbone. For example, the combination of salen(tBu)AlBr (two
methylene units) with alkyl phosphate in a 1:1 stoichiometry produces the polymer, and the
combination of salpen(tBu)AlBr (three methylene units) produces the dimer. While these
compounds show structural variations, there are some common features among these
compounds such as: non-volatility, high melting point (200 – 300 °C), and the presence of a
stable, covalent Al – O – P linkage. Thus, the nerve agents can be both deactivated and locked
into salen units at the same time. Also, these compounds do not decompose in neutral water,
which is an additional advantage in the use of SalenAlBr compounds in the deactivation of nerve
agents. Most of the molecular aluminum phosphates reported in the literature exhibit four or
five coordinated aluminum. The resulting products of the dealkytion reactions contain a six-
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coordinated aluminum, which is rare for molecular aluminophosphate materials. Also, the
reaction conditions for all these compounds are very mild. Hence, this method could be
developed to prepare aluminophosphate ring, cage, or chain structures for soluble models of
aluminophosphate materials. This will be an additional application of dealkylation reaction
beside the potential application in deactivation of nerve agents and pesticides. Although the
attempts to isolate a single crystal of fully dealkylated products, [{Salen(tBu)AlO}3P(O)], were not
successful, these compounds were characterized by spectroscopic and spectrometric analysis.
The isotope patterns from the MALDI mass spectra of these compounds show a very good
match with the isotope patterns obtained from the simulation experiment. This could be
considered as evidence for formation of such compounds.
The salen aluminum bromide compounds used in this research dealkylate
organophosphates effectively in non-nucleophilic solvents. However, for the possible
applications, destruction of nerve agents and pesticides, dealkylation should be carried out in
water. As a first step towards a water-stable dealkylation system, attempts have been made to
examine the effect of strong donor solvents like methanol or water in dealkylation reaction. It
appears that the solvent molecule, which is a stronger nucleophile, compared to the phosphate,
block the coordinating site of aluminum. Percent dealkylation in donor solvents is lower
compared to non-nucleophilic solvent. However, longer reaction time and excess of salen
aluminum reagent might result in increase in dealkylation. Next step was to synthesize watersoluble group 13 chelates. This was achieved by introducing a sulfonate group on a salen ligand.
Although salen(SO3Na)MNO3 (M = Al, Ga), water soluble group 13 chelates, do not how any
activity in dealkylation of organophosphate, this work will be useful in the creation of a waterstable dealkylating system in the future.
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In collaboration with Edgewood Chemical Biological Center, we have developed a
detection method for nerve agents based on the ESI-MS technique. Salen(tBu) Al acetate,
obtained by combination of SAB and sodium acetate, forms Lewis acid base adducts with nerve
agents and other organophosphate compounds. These adducts are sufficiently stable to allow
detection of nerve agents by ESI/MS. This adducts give distinctive mass spectrometry signatures.
Molecular ion peaks were detected for adducts with GB, GD, and EMPA (VX hydrolysis product).
Nerve agents are difficult to analyze by LC/MS due to low ionization efficiency and identification
by GC-MS required prior derivatization. The adduct formation with Salen aluminum compounds
may be viewed as a promising way for detection of nerve agents in aqueous solution with
greater sensitivity.
The studies described in this dissertation could be the useful to carry out more
expanded studies in the future. Toxic nerve agents can be deactivated by salenAlBr but it would
be necessary to determine the toxicity of resulting salen aluminum phosphate compound. The
detection study could be expanded to develop detection method for pesticides and other toxic
OPs. Also detailed quantification study should be undertaken to confirmed applicability.
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Appendix

Figure A1. Crystal Structure of 7 viewed down the c-axis showing staggered confirmation of
t

Bu groups
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Figure A2. Crystal packing of 8 viewed down the a-axis showing stacking of aluminophosphate
rings
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Figure A1. Asymmetric unit of 6 (tBu groups not shown for clarity)

Figure A4. Crystal Structure of Salcen(tBu)AlOC(O)Me
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Table A1. Crystallographic data and refinement details for compound 5-8
5

6

Empirica

C73.42H114..84N4O12

C177H226Al4Cl2N8O24

Formula

P2

P4

1461.94

3152.26

Formula
Weight

7
C38H52AlN2O6P

8
C39H62AlN2O6
P

690.77

712.86

0.12 × 0.12 ×

0.18 × 0.14 ×

0.08

0.04

Crystal

0.20 × 0.04 ×

Size (mm)

0.03

λ (Å)

1.54178

1.54178

1.54178

1.54178

Crystal system

Orthorhombic

Orthorhombic

Tetragonal

Monoclinic

Space group

P 2 1 21 21

Fddd

P 41 2 2

P21/c

a/ Å

17.0858(4)

31.4350(6)

13.9887(2)

16.3345(3)

b/ Å

19.2770(4)

43.7636(8)

13.9887(2)

13.0287(2)

c/ Å

24.6768(6)

50.3936(9)

13.9887(2)

21.0652(3)

α/ °

90.00

90.00

90.00

90.00

β/ °

90.00

90.00

90.00

90.00

γ/ °

90.00

90.00

90.00

90.00

V/ (Å-3)

8127.6(3)

69327(2)

8948.8(3)

4226.26(12)

Z

4

16

8

4

ρcalc /mg m-3

1.195

1.208

1.025

1.120

μ/ mm-1

2.013

1.422

1.048

1.118

F(000)

3134

26912

2960

1544

θ range / °

2.91-68.68

1.94-68.63

3.30 -68.51º

4.06-67.96

–20 ≤ h ≤ 20

0 ≤ h ≤ 37

–16 ≤ h ≤ 16

–19 ≤ h ≤ 19

–23 ≤ k ≤ 18

0 ≤ k ≤ 52

–16 ≤ k ≤ 16

–15 ≤ k ≤ 15

–29 ≤ l ≤ 29

0 ≤ l ≤ 60

–55 ≤ l ≤ 48

–25 ≤ l ≤ 25

111047

15968

127767

59536

14729, 0.0745

15968, 0.0873

8235, 0.0613

7673, 0.0400

Full-matrix least-

Full-matrix least-

Full-matrix

Full-matrix

hkl range

Reflections
collected
Reflection
unique, R(int)
Refinement

0.18 × 0.10 × 0.08
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method

Restraints/

squares on F2

squares on F2

least-squares

least-squares

on F2

on F2

10 / 923

126 / 1132

169 / 455

6 / 471

R1 = 0.0434, wR2

R1 = 0.0534,

R1 = 0.0388,

R1 = 0.0390,

= 0.0999

wR2 = 0.1675

wR2 = 0.1012

wR2 = 0.1003

R indices (all

R1 = 0.0579, wR2

R1 = 0.0712,

R1 = 0.0410,

R1 = 0.0410,

data)

= 0.1088

wR2 = 0.1851

wR2 = 0.1026

wR2 = 0.1002

1.046

1.139

1.088

0.975

0.412 and -0.372

0.524 and -0.484

0.184 and –

0.385 and -

0.308

0.341

parameters
Final R indices

Goodness-offit on F2
Largest diff.
peak and hole
(e.Å-3)
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Table A2. Crystallographic data and refinement details for compound 5-8
15

θ range / °

Empirical

1.75-27.48
–15 ≤ h ≤ 15

C7H9NaO7S

Formula

hkl range

–14 ≤ k ≤ 15
–9 ≤ l ≤ 9

Formula Weight

260.19
Reflections
0.35 × 0.20 ×

Crystal Size (mm)

collected

14329

0.18
Reflection unique,

Wavelength (Å)

0.71073

Crystal system

Monoclinic

Space group

P21/c

R(int)
Refinement
method

a/ Å

11.9935(2)

b/ Å

11.9750(3)

c/ Å

7.0803(3)

α/ °

90.00º

β/ °

103.58º

R indices (all

γ/ °

90.00º

data)

Volume (Å-3)

988.43(5)

Goodness-of-fit on

4

F2

Final R indices

1.748

and hole (e.Å-3)

Density (Mg/m-3)
Absorption
coefficient
F(000)

least-squares on
F2
6/ 159
R1 = 0.0453,
wR2 = 0.1141

Largest diff. peak

Calculated

Full-matrix

Restraints/
parameters

Z

2259, 0.0600

0.389

(mm-1)
536

95

R1 = 0.0565,
wR2 = 0.1206

1.125

0.583 and 0.549

Figure A5. A. Calibration curve using polystyrene standards and with diphenyl ether ; B. GPC
elution curve of diphenyl ether

a

b

Figure A6. A. GPC elution curve of 7; B. GPC elution curve of 8.
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Kendler, S.; Zaltsman, A.; Frishman, G. Instrum Sci. Technol. 2003, 31, 317.
D'Agostino, P. A.; Provost, L. R.; Brooks, P. W. J. Chromatogr. A 1991, 541, 121.
Wang, Q.; Xie, J.; Gu, M.; Feng, J.; Ruan, J. Chromatographia 2005, 62, 167.
Tørnes, J. A.; Johnsen, B. A. J. Chromatogr. A 1989, 467, 129.
Ciner, F. L.; McCord, C. E.; Plunkett Jr, R. W.; Martin, M. F.; Croley, T. R. J. Chromatogr. B
2007, 846, 42.
Richardson, D. D.; Sadi, B. B. M.; Caruso, J. A. J. Anal. At. Spectrom. 2006, 21, 396.
A. Jegier, J.; Munoz-Hernandez, M.-A.; A. Atwood, D. J. Chem. Soc., Dalton Trans. 1999,
2583.
Chen, P.; Chisholm, M. H.; Gallucci, J. C.; Zhang, X.; Zhou, Z. Inorg. Chem. 2005, 44, 2588.
Muñoz-Hernandez, M.-A.; Keizer, T.; Parkin, S.; Zhang, Y.; Atwood, D. J. Chem.
Crystallogr. 2000, 30, 219.

100

Vita
Education

Master of Science
(2003-2005), Organic chemistry, Mumbai University, Maharashtra, India
Bachelor of Science
(2000-2003), Chemistry, Mumbai University, Maharashtra, India

Work
Experience

Gharda Chemical Limited, Chiplun, India
(2005-2006), Jr. Research Assistant, Pigment division
IPCA Laboratories Limited, Mumbai, India
(2006-2009), Research Officer, API research division

Awards

J. R. D. Tata Trust Award for quality academic achievement by Master’s student
Awarded by J.R.D. Tata Trust. 2003 and 2004
Departmental Merit Scholarship
Awarded by Department of Chemistry, Mumbai University, India. 2004-05

Publications

Raman, B.; Sharma, B. A.; Butala, R.; Ghugare, P. D.; Kumar, A., Structural elucidation
of a process-related impurity in ezetimibe by LC/MS/MS and NMR. J. Pharm. Biomed.
Anal. 2010, 52, 73-78.
Butala, R. R.; Cooper, J. K.; Mitra, A.; Webster, M. K.; Atwood, D. A., Dealkylation of
chemical weapon agents and pesticides with group 13 salen compounds. Main Group
Chem. 2010, 9 (3), 315-335.
Butala, R.R.; Atwood, D. A., Aluminum: Organometallics. In Comprehensive
Organometallic Chemistry III; Robert, H. C.; Mingos, D. M. P., Ed.; Elsevier: Oxford
University Press, 2013; pp 265-285. (Updated of original article by Mitra, A.; Atwood,
D. A. 2007)
Butala, R. R.; Creasy, W, R.; Frye, R. A.; Atwood, D. A., Lewis Acid Assisted Detection of
Nerve Agents in Water. Chem. Commun. (To be submitted).
Butala, R. R.; Parkin, S.; Atwood, D. A., Salen Aluminum Phosphates. To be submitted,
Inorg. Chem. (To be submitted).

101

